PLOD-CW-25-Val.conll

Multi ADJ B-LF
- PUNCT I-LF
locus ADJ I-LF
sequence NOUN I-LF
typing NOUN I-LF
( PUNCT O
MLST NOUN B-AC
) PUNCT O
was AUX O
performed VERB O
by ADP O
PCR NOUN B-AC
- PUNCT O
sequencing NOUN O
of ADP O
a DET O
set NOUN O
of ADP O
pneumococcal ADJ O
housekeeping NOUN O
genes NOUN O
, PUNCT O
including VERB O
ardE NOUN O
, PUNCT O
gdh NOUN O
, PUNCT O
gki NOUN O
, PUNCT O
recP NOUN O
, PUNCT O
spi NOUN O
, PUNCT O
xpt NOUN O
, PUNCT O
and CCONJ O
ddl NOUN O
[ PUNCT O
17 NUM O
] PUNCT O
. PUNCT O

The DET O
investigated VERB O
traits NOUN O
were AUX O
heading NOUN B-LF
date NOUN I-LF
( PUNCT O
HD PROPN B-AC
) PUNCT O
, PUNCT O
plant NOUN B-LF
height NOUN I-LF
( PUNCT O
PH PROPN B-AC
) PUNCT O
, PUNCT O
GY PROPN B-AC
, PUNCT O
thousand NUM B-LF
grain NOUN I-LF
weight NOUN I-LF
( PUNCT O
TGW PROPN B-AC
) PUNCT O
, PUNCT O
weight NOUN O
of ADP O
straw NOUN O
– PUNCT O
referred VERB O
to ADP O
as ADP O
straw NOUN B-LF
yield NOUN I-LF
( PUNCT O
SY PROPN B-AC
) PUNCT O
, PUNCT O
spike NOUN B-LF
number NOUN I-LF
per ADP I-LF
meter NOUN I-LF
( PUNCT O
SN PROPN B-AC
) PUNCT O
, PUNCT O
grain NOUN B-LF
number NOUN I-LF
per ADP I-LF
spike NOUN I-LF
( PUNCT O
GN PROPN B-AC
) PUNCT O
, PUNCT O
harvest NOUN B-LF
index NOUN I-LF
( PUNCT O
HI PROPN B-AC
) PUNCT O
, PUNCT O
N NOUN B-LF
harvest NOUN I-LF
index NOUN I-LF
( PUNCT O
NHI PROPN B-AC
) PUNCT O
, PUNCT O
GPC PROPN B-AC
, PUNCT O
NUE PROPN B-AC
, PUNCT O
NUpE PROPN B-AC
, PUNCT O
NUtE PROPN B-AC
, PUNCT O
amount NOUN O
of ADP O
N NOUN O
taken VERB O
up ADP O
by ADP O
the DET O
whole ADJ O
plant NOUN O
( PUNCT O
NUpfull PROPN B-AC
) PUNCT O
, PUNCT O
amount NOUN O
of ADP O
the DET O
N NOUN O
harvested VERB O
in ADP O
grain NOUN O
( PUNCT O
NUpgrain PROPN B-AC
) PUNCT O
, PUNCT O
grain NOUN B-LF
N NOUN I-LF
accumulation NOUN I-LF
efficiency NOUN I-LF
( PUNCT O
GNACE PROPN B-AC
) PUNCT O
. PUNCT O
GY PROPN B-AC
, PUNCT O
HD PROPN B-AC
and CCONJ O
PH PROPN B-AC
were AUX O
scored VERB O
on ADP O
a DET O
per ADP O
plot NOUN O
basis NOUN O
, PUNCT O
while SCONJ O
GN PROPN B-AC
, PUNCT O
SN PROPN B-AC
, PUNCT O
TGW PROPN B-AC
and CCONJ O
SY PROPN B-AC
were AUX O
evaluated VERB O
from ADP O
above ADP O
- PUNCT O
ground NOUN O
biomass NOUN O
samples NOUN O
collected VERB O
from ADP O
a DET O
representative ADJ O
row NOUN O
of ADP O
each DET O
plot NOUN O
, PUNCT O
whose DET O
length NOUN O
was AUX O
one NUM O
meter NOUN O
. PUNCT O

AVR PROPN B-AC
- PUNCT O
Aortic ADJ B-LF
valve NOUN I-LF
replacement NOUN I-LF
, PUNCT O
TAVI PROPN B-AC
– PUNCT O
transcutaneous ADJ O
aortic ADJ O
valve NOUN O
implantation NOUN O

After ADP O
amelogenin NOUN O
, PUNCT O
ameloblastin NOUN B-LF
( PUNCT O
AMBN PROPN B-AC
) PUNCT O
is AUX O
the DET O
second ADV O
most ADV O
abundant ADJ O
enamel NOUN O
matrix NOUN O
protein NOUN O
. PUNCT O

To PART O
address VERB O
the DET O
association NOUN O
between ADP O
a DET O
history NOUN O
of ADP O
tuberculosis NOUN B-LF
( PUNCT O
TB PROPN B-AC
) PUNCT O
or CCONJ O
nontuberculous ADJ O
mycobacterial ADJ O
( PUNCT O
NTM PROPN B-AC
) PUNCT O
infection NOUN O
and CCONJ O
the DET O
risk NOUN O
of ADP O
newly ADV O
diagnosed VERB O
Sjögren PROPN B-LF
’s PART I-LF
syndrome NOUN I-LF
( PUNCT O
SS PROPN B-AC
) PUNCT O
. PUNCT O

As SCONJ O
SIRS PROPN B-AC
caused VERB O
by ADP O
tissue NOUN O
damage NOUN O
increases VERB O
the DET O
release NOUN O
of ADP O
damage NOUN B-LF
- PUNCT I-LF
associated VERB I-LF
molecular ADJ I-LF
patterns NOUN I-LF
( PUNCT O
DAMPs PROPN B-AC
) PUNCT O
, PUNCT O
SIRS PROPN B-AC
becomes VERB O
more ADV O
severe ADJ O
and CCONJ O
the DET O
multiple ADJ O
organ NOUN O
failure NOUN O
of ADP O
the DET O
patient NOUN O
worsens VERB O
. PUNCT O

EV PROPN B-AC
, PUNCT O
extracellular ADJ B-LF
vesicle NOUN I-LF
; PUNCT O
NSC PROPN B-AC
, PUNCT O
neural ADJ B-LF
stem NOUN I-LF
cell NOUN I-LF
; PUNCT O
WB PROPN B-AC
, PUNCT O
western ADJ B-LF
blot NOUN I-LF
. PUNCT O

The DET O
same ADJ O
experiment NOUN O
was AUX O
also ADV O
conducted VERB O
in ADP O
the DET O
2011 NUM O
DS PROPN B-AC
, PUNCT O
2011 NUM O
WS PROPN B-AC
and CCONJ O
2012 NUM O
WS PROPN B-AC
but CCONJ O
only ADV O
phenology NOUN O
and CCONJ O
final ADJ O
crop NOUN O
aboveground ADJ B-LF
dry ADJ I-LF
weight NOUN I-LF
( PUNCT O
agdw NOUN B-AC
) PUNCT O
are AUX O
reported VERB O
here ADV O
. PUNCT O

Of ADP O
these PRON O
, PUNCT O
Nucleolar ADJ B-LF
and CCONJ I-LF
spindle NOUN I-LF
- PUNCT I-LF
associated VERB I-LF
protein NOUN I-LF
1 NUM I-LF
( PUNCT O
NUSAP1 PROPN B-AC
) PUNCT O
was AUX O
detected VERB O
as ADP O
a DET O
significantly ADV O
upregulated VERB O
gene NOUN O
. PUNCT O

Mitochondrial ADJ O
fusion NOUN O
/ SYM O
fission NOUN O
is AUX O
primarily ADV O
regulated VERB O
by ADP O
dynamin NOUN O
- PUNCT O
like ADJ O
GTPase PROPN O
, PUNCT O
optic ADJ B-LF
atrophy NOUN I-LF
1 NUM I-LF
( PUNCT O
Opa1 PROPN B-AC
) PUNCT O
and CCONJ O
dynamin NOUN B-LF
- PUNCT I-LF
related VERB I-LF
protein NOUN I-LF
1 NUM I-LF
( PUNCT O
Drp1 PROPN B-AC
, PUNCT O
mitofusin NOUN O
1/2 NUM O
( PUNCT O
Mfn1/2 NOUN O
) PUNCT O
[ PUNCT O
40–42 NUM O
] PUNCT O
. PUNCT O

We PRON O
carried VERB O
out ADP O
a DET O
series NOUN O
of ADP O
experimental ADJ O
studies NOUN O
in ADP O
order NOUN O
to PART O
obtain VERB O
behavioural ADJ O
data NOUN O
from ADP O
rats NOUN O
given VERB O
low ADJ O
, PUNCT O
medium ADJ O
, PUNCT O
and CCONJ O
high ADJ O
doses NOUN O
of ADP O
peptide NOUN B-LF
YY3 PROPN I-LF
- PUNCT I-LF
36 NUM I-LF
( PUNCT O
PYY3 PROPN B-AC
- PUNCT B-AC
36 NUM B-AC
) PUNCT O
in ADP O
the DET O
light ADJ O
and CCONJ O
dark ADJ O
period NOUN O
, PUNCT O
as ADP O
well ADV O
as ADP O
rats NOUN O
given VERB O
low ADJ O
and CCONJ O
high ADJ O
doses NOUN O
of ADP O
lithium NOUN O
chloride NOUN O
( PUNCT O
LiCl PROPN O
) PUNCT O
in ADP O
the DET O
light ADJ O
period NOUN O
and CCONJ O
rats NOUN O
given VERB O
low ADJ O
, PUNCT O
medium ADJ O
, PUNCT O
and CCONJ O
high ADJ O
doses NOUN O
of ADP O
glucagon NOUN B-LF
- PUNCT I-LF
like ADJ I-LF
peptide NOUN I-LF
1 NUM I-LF
( PUNCT O
GLP-1 PROPN B-AC
) PUNCT O
and CCONJ O
leptin NOUN O
in ADP O
the DET O
dark ADJ O
period NOUN O
( PUNCT O
details NOUN O
and CCONJ O
doses NOUN O
in ADP O
Table PROPN O
2 NUM O
and CCONJ O
Materials NOUN O
and CCONJ O
Methods NOUN O
) PUNCT O
. PUNCT O

Olfactory ADJ B-LF
sensory ADJ I-LF
neurons NOUN I-LF
( PUNCT O
OSNs PROPN B-AC
) PUNCT O
in ADP O
most ADJ O
vertebrates NOUN O
and CCONJ O
insects NOUN O
are AUX O
specified VERB O
to PART O
express VERB O
a DET O
single ADJ O
odorant NOUN B-LF
receptor NOUN I-LF
( PUNCT O
OR PROPN B-AC
) PUNCT O
from ADP O
a DET O
large ADJ O
repertoire NOUN O
of ADP O
OR PROPN B-AC
genes NOUN O
in ADP O
the DET O
genome NOUN O
[ X O
1–4 NUM O
] PUNCT O
. PUNCT O

Combined ADJ B-LF
hepatocellular ADJ I-LF
- PUNCT I-LF
cholangiocarcinoma NOUN I-LF
( PUNCT O
cHCC NOUN B-AC
- PUNCT B-AC
CC NOUN B-AC
) PUNCT O
accounts VERB O
for ADP O
0.4%–14.2 NUM O
% NOUN O
of ADP O
primary ADJ O
liver NOUN O
malignancies NOUN O
[ PUNCT O
1 NUM O
, PUNCT O
2 NUM O
] PUNCT O
, PUNCT O
and CCONJ O
contains VERB O
pathological ADJ O
components NOUN O
of ADP O
both CCONJ O
hepatocellular ADJ B-LF
carcinoma NOUN I-LF
( PUNCT O
HCC PROPN B-AC
) PUNCT O
and CCONJ O
cholangiocarcinoma NOUN B-LF
( PUNCT O
CC NOUN B-AC
) PUNCT O
[ PUNCT O
3 NUM O
] PUNCT O
. PUNCT O

“ PUNCT O
Post PROPN O
- ADJ O
Tax ADJ O
: PUNCT O
Behavior NOUN O
Only ADV O
” PUNCT O
refers VERB O
to ADP O
estimates NOUN O
of ADP O
beverage NOUN O
intake NOUN O
using VERB O
only ADV O
the DET O
pre ADJ O
- ADJ O
tax ADJ O
food NOUN B-LF
composition NOUN I-LF
table NOUN I-LF
( PUNCT O
FCT PROPN B-AC
) PUNCT O
, PUNCT O
which PRON O
keeps VERB O
nutrient NOUN O
content NOUN O
constant ADJ O
. PUNCT O
“ PUNCT O
Post PROPN O
- ADJ O
Tax ADJ O
: PUNCT O
Reformulation NOUN O
Included VERB O
” PUNCT O
refers VERB O
to ADP O
estimates NOUN O
of ADP O
beverage NOUN O
intake NOUN O
using VERB O
the DET O
post ADJ O
- ADJ O
tax ADJ O
FCT PROPN B-AC
, PUNCT O
which PRON O
accounts VERB O
for ADP O
reformulation NOUN O
changes NOUN O
in ADP O
the DET O
nutrient NOUN O
content NOUN O
of ADP O
beverages NOUN O
. PUNCT O

b X O
GH NOUN B-AC
: PUNCT O
growth NOUN B-LF
hormone NOUN I-LF

IES PROPN B-AC
, PUNCT O
internal ADJ B-LF
eliminated VERB I-LF
sequence NOUN I-LF
. PUNCT O

Compared VERB O
to ADP O
the DET O
X NOUN O
- PUNCT O
ray NOUN O
crystal NOUN O
structure NOUN O
of ADP O
the DET O
template NOUN O
( PUNCT O
PDB NOUN O
code NOUN O
4F13 NUM O
) PUNCT O
[ PUNCT O
32 NUM O
] PUNCT O
, PUNCT O
the DET O
geometrical ADJ O
root NOUN B-LF
- PUNCT I-LF
mean NOUN I-LF
square ADJ I-LF
deviation NOUN I-LF
( PUNCT O
RMSD NOUN B-AC
) PUNCT O
for ADP O
the DET O
Cα PROPN O
atoms NOUN O
of ADP O
the DET O
modeled VERB O
AlgL PROPN B-AC
structure NOUN O
was AUX O
very ADV O
low ADJ O
( PUNCT O
1.03 NUM O
Å NOUN O
) PUNCT O
, PUNCT O
suggesting VERB O
the DET O
high ADJ O
fidelity NOUN O
of ADP O
the DET O
modeled VERB O
structure NOUN O
. PUNCT O

CI PROPN B-AC
, PUNCT O
confidence NOUN B-LF
interval NOUN I-LF
; PUNCT O
non ADJ O
- ADJ O
UHCS ADJ B-AC
, PUNCT O
non ADJ O
- ADJ O
universal ADJ B-LF
health NOUN I-LF
care NOUN I-LF
system NOUN I-LF
; PUNCT O
NR PROPN O
, PUNCT O
not PART O
reported VERB O
; PUNCT O
OR PROPN B-AC
, PUNCT O
odds NOUN B-LF
ratio NOUN I-LF
; PUNCT O
SEER PROPN B-AC
, PUNCT O
National PROPN B-LF
Cancer PROPN I-LF
Institute PROPN I-LF
's PART I-LF
Surveillance PROPN I-LF
, PUNCT I-LF
Epidemiology PROPN I-LF
and CCONJ I-LF
End PROPN I-LF
Results PROPN I-LF
database NOUN O
; PUNCT O
SEP PROPN B-AC
, PUNCT O
socioeconomic ADJ B-LF
position NOUN I-LF
. PUNCT O

Past ADJ O
studies NOUN O
have AUX O
found VERB O
an DET O
association NOUN O
between ADP O
low ADJ O
levels NOUN O
of ADP O
hemoglobin NOUN B-LF
A1c NOUN I-LF
( PUNCT O
HbA1c NOUN B-AC
, PUNCT O
a DET O
marker NOUN O
of ADP O
average ADJ O
blood NOUN O
sugar NOUN O
levels NOUN O
over ADP O
the DET O
past ADJ O
2–3 NUM O
months NOUN O
; PUNCT O
a DET O
low ADJ O
HbA1c NOUN B-AC
percentage NOUN O
indicates VERB O
good ADJ O
glycemic ADJ O
control NOUN O
) PUNCT O
and CCONJ O
a DET O
high ADJ O
risk NOUN O
of ADP O
severe ADJ O
hypoglycemia NOUN O
. PUNCT O

Abbreviations NOUN O
: NOUN O
mPAP PROPN B-AC
= VERB O
mean ADJ B-LF
pulmonary ADJ I-LF
artery NOUN I-LF
pressure NOUN I-LF
; PUNCT O
PA PROPN B-AC
: NOUN B-AC
A NOUN B-AC
= VERB O
pulmonary ADJ B-LF
artery NOUN I-LF
to ADP O
ascending ADJ O
aorta NOUN O
diameter NOUN O
ratio NOUN O
; PUNCT O
PH NOUN B-AC
= VERB O
pulmonary ADJ B-LF
hypertension NOUN I-LF
. PUNCT O

PUD PROPN B-AC
; PUNCT O
Peptic ADJ B-LF
Ulcer NOUN I-LF
Disease NOUN I-LF

Specifically ADV O
, PUNCT O
administration NOUN O
of ADP O
the DET O
TB PROPN B-AC
vaccine NOUN O
bacillus NOUN B-LF
Calmette PROPN I-LF
– PUNCT I-LF
Guérin PROPN I-LF
( PUNCT O
BCG PROPN B-AC
) PUNCT O
or CCONJ O
measles NOUN O
vaccines NOUN O
in ADP O
children NOUN O
reduces VERB O
overall ADJ O
mortality NOUN O
by ADP O
more ADJ O
than ADP O
what PRON O
would AUX O
be AUX O
expected VERB O
by ADP O
prevention NOUN O
of ADP O
these DET O
2 NUM O
diseases NOUN O
alone ADV O
[ PUNCT O
12 NUM O
] PUNCT O
. PUNCT O

To PART O
test VERB O
this DET O
hypothesis NOUN O
, PUNCT O
we PRON O
predicted VERB O
errors NOUN O
in ADP O
the DET O
reported VERB O
diameter NOUN O
size NOUN O
of ADP O
the DET O
retro ADJ O
- ADJ O
cued VERB O
circle NOUN O
as ADP O
a DET O
function NOUN O
of ADP O
the DET O
competitor(s NOUN B-LF
) PUNCT I-LF
relative ADJ I-LF
size NOUN I-LF
( PUNCT O
ΔC NOUN B-AC
) PUNCT O
and CCONJ O
of ADP O
the DET O
ΔS NOUN B-AC
— PUNCT O
i.e. X O
, PUNCT O
the DET O
difference NOUN O
between ADP O
the DET O
previous ADJ O
and CCONJ O
the DET O
current ADJ O
target NOUN O
circle NOUN O
’s PART O
size NOUN O
. PUNCT O

The DET O
second ADJ O
group NOUN O
“ PUNCT O
Complete PROPN B-LF
Granulation PROPN I-LF
Bed PROPN I-LF
” PUNCT O
( PUNCT O
CGB PROPN B-AC
) PUNCT O
included VERB O
wounds NOUN O
with ADP O
a DET O
complete ADJ B-LF
granulation NOUN I-LF
bed NOUN I-LF
, PUNCT O
or CCONJ O
only ADV O
minor ADJ O
clefts NOUN O
or CCONJ O
defects NOUN O
of ADP O
less ADJ O
than ADP O
0.5 NUM O
cm NOUN O
depth NOUN O
. PUNCT O

IFOF PROPN B-AC
, PUNCT O
inferior ADJ B-LF
fronto ADJ I-LF
- PUNCT I-LF
occipital ADJ I-LF
fascicle NOUN I-LF
; PUNCT O
ILF PROPN B-AC
, PUNCT O
inferior ADJ B-LF
longitudinal ADJ I-LF
fascicle NOUN I-LF
; PUNCT O
ILFlat PROPN B-AC
, PUNCT O
inferior ADJ B-LF
longitudinal ADJ I-LF
fascicle NOUN I-LF
lateral ADJ O
; PUNCT O
ILFmed PROPN B-AC
, PUNCT O
inferior ADJ B-LF
longitudinal ADJ I-LF
fascicle NOUN I-LF
medial ADJ O
; PUNCT O
KL PROPN B-AC
, PUNCT O
Kullback PROPN B-LF
– PUNCT I-LF
Liebler PROPN I-LF
; PUNCT O
MdLF PROPN B-AC
, PUNCT O
middle ADJ B-LF
longitudinal ADJ I-LF
fascicle NOUN I-LF
; PUNCT O
PRIME PROPN O
- PUNCT O
DE PROPN O
, PUNCT O
Primate PROPN O
Data PROPN O
Exchange PROPN O
. PUNCT O

Abbreviations NOUN O
: PUNCT O
BP PROPN B-AC
, PUNCT O
blood NOUN B-LF
pressure NOUN I-LF
; PUNCT O
sBP NOUN B-AC
, PUNCT O
systolic ADJ B-LF
blood NOUN I-LF
pressure NOUN I-LF
. PUNCT O

Integrated VERB O
muscle NOUN O
protein NOUN O
balance NOUN O
has AUX O
been AUX O
calculated VERB O
for ADP O
the DET O
following VERB O
periods NOUN O
of ADP O
time NOUN O
: PUNCT O
post ADJ B-LF
absorptive ADJ I-LF
period NOUN O
( PUNCT O
PA NOUN B-AC
) PUNCT O
( PUNCT O
0–150min NUM O
) PUNCT O
, PUNCT O
early ADJ O
post ADJ B-LF
prandial ADJ I-LF
period NOUN O
( PUNCT O
PP NOUN B-AC
) PUNCT O
( PUNCT O
150–300min NUM O
) PUNCT O
and CCONJ O
late ADJ O
post ADJ B-LF
prandial ADJ I-LF
period NOUN O
( PUNCT O
PP NOUN B-AC
) PUNCT O
( PUNCT O
300–550min NUM O
) PUNCT O
. PUNCT O

Multiple ADJ O
sources NOUN O
were AUX O
used VERB O
, PUNCT O
integrating VERB O
the DET O
hospital NOUN B-LF
discharge NOUN I-LF
register NOUN I-LF
( PUNCT O
HDR PROPN B-AC
) PUNCT O
, PUNCT O
clinical ADJ O
charts NOUN O
, PUNCT O
spirometry NOUN O
and CCONJ O
the DET O
cause NOUN B-LF
- PUNCT I-LF
specific ADJ I-LF
mortality NOUN I-LF
register NOUN I-LF
( PUNCT O
CMR PROPN B-AC
) PUNCT O
in ADP O
a DET O
longitudinal ADJ O
algorithm NOUN O
, PUNCT O
to PART O
reduce VERB O
underestimation NOUN O
of ADP O
COPD PROPN B-AC
prevalence NOUN O
. PUNCT O

Unadjusted ADJ O
prevalence NOUN B-LF
risk NOUN I-LF
ratios NOUN I-LF
( PUNCT O
PRRs NOUN B-AC
) PUNCT O
and CCONJ O
adjusted VERB O
PRRs NOUN B-AC
( PUNCT O
adjPRRs NOUN B-AC
) PUNCT O
of ADP O
HIV PROPN O
shedding NOUN O
were AUX O
estimated VERB O
using VERB O
modified VERB O
Poisson PROPN O
regression NOUN O
with ADP O
robust ADJ O
variance NOUN O
. PUNCT O

The DET O
myocardial ADJ O
extracellular ADJ B-LF
matrix NOUN I-LF
( PUNCT O
ECM PROPN B-AC
) PUNCT O
is AUX O
a DET O
critical ADJ O
component NOUN O
in ADP O
normal ADJ O
and CCONJ O
pathophysiological ADJ O
conditions NOUN O
of ADP O
the DET O
heart NOUN O
, PUNCT O
and CCONJ O
is AUX O
mainly ADV O
regulated VERB O
by ADP O
cardiac ADJ O
fibroblasts NOUN O
[ PUNCT O
1 NUM O
] PUNCT O
. PUNCT O

Furthermore ADV O
, PUNCT O
the DET O
complete ADJ O
lack NOUN O
of ADP O
access NOUN O
to ADP O
health NOUN O
care NOUN O
, PUNCT O
absence NOUN O
of ADP O
skilled ADJ O
delivery NOUN O
services NOUN O
, PUNCT O
or CCONJ O
delayed VERB O
entry NOUN O
into ADP O
antenatal ADJ B-LF
care NOUN I-LF
( PUNCT O
ANC PROPN B-AC
) PUNCT O
deprive VERB O
both CCONJ O
the DET O
teenage ADJ O
mother NOUN O
and CCONJ O
her PRON O
offspring NOUN O
of ADP O
basic ADJ O
health NOUN O
care NOUN O
services NOUN O
[ PUNCT O
4 NUM O
] PUNCT O
. PUNCT O

This DET O
antiviral ADJ O
response NOUN O
is AUX O
triggered VERB O
by ADP O
virus NOUN O
- PUNCT O
specific ADJ O
double ADJ B-LF
- PUNCT I-LF
stranded ADJ I-LF
RNA NOUN I-LF
molecules NOUN O
( PUNCT O
dsRNAs NOUN B-AC
) PUNCT O
that PRON O
are AUX O
produced VERB O
during ADP O
infection NOUN O
. PUNCT O

The DET O
receiver NOUN B-LF
operating NOUN I-LF
characteristic NOUN I-LF
( PUNCT O
ROC PROPN B-AC
) PUNCT O
curves NOUN O
show VERB O
the DET O
discrimination NOUN O
of ADP O
the DET O
model NOUN O
after ADP O
including VERB O
empirically ADV O
diagnosed VERB O
TB PROPN B-AC
patients NOUN O
in ADP O
the DET O
study NOUN O
population NOUN O
. PUNCT O

Furthermore ADV O
, PUNCT O
in ADP O
patients NOUN O
with ADP O
HCV PROPN B-AC
- ADJ O
related VERB O
cirrhosis NOUN O
, PUNCT O
the DET O
primary ADJ O
necro ADJ O
- ADJ O
inflammatory ADJ O
stimulus NOUN O
( PUNCT O
i.e. X O
the DET O
hepatitis PROPN B-LF
C PROPN I-LF
virus NOUN I-LF
) PUNCT O
is AUX O
still ADV O
present ADJ O
, PUNCT O
whereas SCONJ O
in ADP O
ALD PROPN B-AC
or CCONJ O
NAFLD PROPN B-AC
- ADJ O
related VERB O
cirrhosis NOUN O
, PUNCT O
the DET O
primary ADJ O
necro ADJ O
- ADJ O
inflammatory ADJ O
stimulus NOUN O
( PUNCT O
i.e. X O
alcohol NOUN O
use NOUN O
in ADP O
ALD PROPN B-AC
or CCONJ O
a DET O
hypothesized VERB O
lipotoxic ADJ O
molecule NOUN O
in ADP O
NAFLD PROPN B-AC
) PUNCT O
may AUX O
or CCONJ O
may AUX O
not PART O
still ADV O
be AUX O
present ADJ O
after ADP O
the DET O
development NOUN O
of ADP O
cirrhosis NOUN O
. PUNCT O

PF PROPN B-AC
: PUNCT O
Processed VERB B-LF
foods NOUN I-LF
, PUNCT O
EAR PROPN B-AC
: PUNCT O
Estimated VERB B-LF
average ADJ I-LF
requirement NOUN I-LF
, PUNCT O
RNI PROPN B-AC
: PUNCT O
Recommended VERB B-LF
nutrient NOUN I-LF
intake NOUN I-LF
, PUNCT O
UL PROPN B-AC
: PUNCT O
Tolerable ADJ B-LF
upper ADJ I-LF
intake NOUN I-LF
limit NOUN I-LF
; PUNCT O
for ADP O
iodine NOUN O
. PUNCT O

To PART O
measure VERB O
the DET O
social ADJ O
deprivation NOUN O
of ADP O
the DET O
area NOUN O
of ADP O
residence NOUN O
we PRON O
used VERB O
the DET O
Welsh PROPN B-LF
Index PROPN I-LF
of ADP I-LF
Multiple PROPN I-LF
Deprivation PROPN I-LF
( PUNCT O
WIMD PROPN B-AC
) PUNCT O
2005 NUM O
at ADP O
lower ADJ B-LF
super ADJ I-LF
output NOUN I-LF
area NOUN I-LF
( PUNCT O
LSOA PROPN B-AC
) PUNCT O
level NOUN O
, PUNCT O
equivalent ADJ O
to ADP O
a DET O
postcode NOUN O
area NOUN O
with ADP O
a DET O
minimum NOUN O
of ADP O
1000 NUM O
houses NOUN O
and CCONJ O
mean ADJ O
1500 NUM O
houses NOUN O
[ PUNCT O
29 NUM O
] PUNCT O
. PUNCT O

Arp2/3 NOUN B-AC
, PUNCT O
actin NOUN B-LF
- PUNCT I-LF
related VERB I-LF
protein NOUN I-LF
2/3 NUM I-LF
; PUNCT O
CK-666 NOUN B-AC
, PUNCT O
Arp2/3 NOUN B-LF
complex NOUN I-LF
inhibitor NOUN I-LF
I NUM I-LF
; PUNCT O
WASp PROPN B-AC
, PUNCT O
Wiskott PROPN B-LF
– PUNCT I-LF
Aldrich PROPN I-LF
syndrome PROPN I-LF
protein NOUN I-LF
. PUNCT O

GA PROPN B-AC
= PUNCT O
general ADJ B-LF
anaesthesia NOUN I-LF
; PUNCT O
MACCE PROPN B-AC
= PUNCT O
major ADJ O
cardiac ADJ O
and CCONJ O
cerebrovascular ADJ O
events NOUN O

In ADP O
response NOUN O
to PART O
these DET O
concerns NOUN O
, PUNCT O
in ADP O
2011 NUM O
, PUNCT O
an DET O
Indian ADJ O
parliamentary ADJ O
standing NOUN O
committee NOUN O
closely ADV O
examined VERB O
the DET O
Indian ADJ O
national ADJ O
drug NOUN O
regulator NOUN O
— PUNCT O
the DET O
Central PROPN O
Drugs PROPN O
Standard PROPN O
Control PROPN O
Organization PROPN O
( PUNCT O
CDSCO PROPN B-AC
) PUNCT O
. PUNCT O
The DET O
committee NOUN O
’s PART O
report NOUN O
, PUNCT O
released VERB O
in ADP O
2012 NUM O
, PUNCT O
highlighted VERB O
multiple ADJ O
deficiencies NOUN O
in ADP O
the DET O
approval NOUN O
processes NOUN O
of ADP O
the DET O
CDSCO PROPN B-AC
, PUNCT O
including VERB O
a DET O
failure NOUN O
to PART O
test VERB O
the DET O
efficacy NOUN O
and CCONJ O
safety NOUN O
of ADP O
many ADJ O
of ADP O
the DET O
FDCs NOUN B-AC
available ADJ O
in ADP O
India PROPN O
, PUNCT O
but CCONJ O
provided VERB O
no DET O
systematic ADJ O
evidence NOUN O
to PART O
support VERB O
its PRON O
concerns NOUN O
about ADP O
FDCs NOUN B-AC
. PUNCT O
Here ADV O
, PUNCT O
the DET O
researchers NOUN O
undertake VERB O
a DET O
time NOUN O
- ADJ O
trend NOUN O
analysis NOUN O
of ADP O
the DET O
sales NOUN O
volumes NOUN O
of ADP O
oral ADJ O
FDCs NOUN B-AC
for ADP O
pain NOUN O
relief NOUN O
( PUNCT O
analgesia NOUN O
; PUNCT O
formulations NOUN O
of ADP O
non ADJ B-LF
- ADJ I-LF
steroidal ADJ I-LF
anti ADJ I-LF
- ADJ I-LF
inflammatory ADJ I-LF
drugs NOUN I-LF
, PUNCT O
NSAIDs PROPN B-AC
) PUNCT O
, PUNCT O
diabetes NOUN O
( PUNCT O
metformin NOUN O
formulations NOUN O
) PUNCT O
, PUNCT O
depression NOUN O
/ SYM O
anxiety NOUN O
( PUNCT O
anti ADJ O
- ADJ O
depressant ADJ O
/ SYM O
benzodiazepine NOUN O
formulations NOUN O
) PUNCT O
, PUNCT O
and CCONJ O
psychosis NOUN O
( PUNCT O
anti ADJ O
- ADJ O
psychotic ADJ O
formulations NOUN O
) PUNCT O
in ADP O
India PROPN O
between ADP O
2007 NUM O
and CCONJ O
2012 NUM O
. PUNCT O

QEESI PROPN B-AC
consisted VERB O
of ADP O
five NUM O
subscales NOUN O
, PUNCT O
each PRON O
with ADP O
10 NUM O
items NOUN O
, PUNCT O
which PRON O
in ADP O
total NOUN O
consisted VERB O
of ADP O
50 NUM O
items NOUN O
: PUNCT O
Q1 NOUN B-AC
Chemical NOUN B-LF
Intolerances NOUN I-LF
, PUNCT O
Q2 PROPN B-AC
Other ADJ B-LF
Intolerances NOUN I-LF
, PUNCT O
Q3 PROPN B-AC
Symptom NOUN B-LF
Severity PROPN I-LF
, PUNCT O
Q4 PROPN O
Masking NOUN O
Index PROPN O
, PUNCT O
and CCONJ O
Q5 PROPN B-AC
Life NOUN B-LF
Impacts NOUN I-LF
. PUNCT O

DD PROPN B-AC
, PUNCT O
constant ADJ B-LF
darkness NOUN I-LF
; PUNCT O
GI PROPN B-AC
, PUNCT O
GIGANTEA PROPN B-LF
; PUNCT O
LUC PROPN B-AC
, PUNCT O
LUCIFERASE PROPN B-LF
. PUNCT O

After ADP O
28 NUM O
days NOUN O
of ADP O
treatment NOUN O
, PUNCT O
both CCONJ O
the DET O
low ADJ O
( PUNCT O
15 NUM O
mg NOUN O
/ SYM O
kg NOUN O
b.w NOUN O
. PUNCT O
) PUNCT O
and CCONJ O
medium ADJ O
dose NOUN O
( PUNCT O
75 NUM O
mg NOUN O
/ SYM O
kg NOUN O
b.w NOUN O
. PUNCT O
) PUNCT O
of ADP O
SSJ PROPN B-AC
prevented VERB O
BW NOUN B-AC
gain NOUN O
but CCONJ O
is AUX O
more ADV O
significant ADJ O
with ADP O
the DET O
one NUM O
dose NOUN O
, PUNCT O
leading VERB O
to ADP O
a DET O
loss NOUN O
of ADP O
almost ADV O
5 NUM O
g NOUN O
in ADP O
body NOUN B-LF
weight NOUN I-LF
( PUNCT O
P<0.01 NUM O
) PUNCT O
compared VERB O
to ADP O
an DET O
average NOUN O
of ADP O
14.7 NUM O
g NOUN O
gained VERB O
by ADP O
the DET O
HFD PROPN B-AC
group NOUN O
. PUNCT O

A DET O
new ADJ O
recently ADV O
introduced VERB O
anthropometric ADJ O
measure NOUN O
, PUNCT O
named VERB O
body NOUN B-LF
shape NOUN I-LF
index NOUN I-LF
( PUNCT O
ABSI PROPN B-AC
) PUNCT O
, PUNCT O
appears VERB O
to PART O
be AUX O
a DET O
substantial ADJ O
risk NOUN O
factor NOUN O
for ADP O
premature ADJ O
mortality NOUN O
in ADP O
the DET O
general ADJ O
population NOUN O
[ PUNCT O
8 NUM O
] PUNCT O
. PUNCT O

OPC PROPN B-AC
, PUNCT O
oligodendrocyte NOUN B-LF
precursor NOUN I-LF
cell NOUN I-LF
; PUNCT O
UMAP PROPN B-AC
, PUNCT O
Uniform PROPN B-LF
Manifold PROPN I-LF
Approximation PROPN I-LF
and CCONJ I-LF
Projection PROPN I-LF
. PUNCT O

Electrophysiological ADJ O
methods NOUN O
, PUNCT O
like ADP O
intracranially ADV O
recorded VERB O
electroencephalography NOUN B-LF
( PUNCT O
EEG NOUN B-AC
) PUNCT O
or CCONJ O
EEG NOUN B-AC
/ SYM O
magnetoencephalography NOUN B-LF
( PUNCT O
MEG PROPN B-AC
) PUNCT O
, PUNCT O
are AUX O
particularly ADV O
promising ADJ O
to PART O
offer VERB O
a DET O
mechanistic ADJ O
understanding NOUN O
of ADP O
memory NOUN O
formation NOUN O
processes NOUN O
. PUNCT O

Patient NOUN O
( PUNCT O
P NOUN O
) PUNCT O
, PUNCT O
Deletion NOUN B-LF
of ADP I-LF
exon NOUN I-LF
3 NUM I-LF
of ADP O
IL10RB PROPN O
( PUNCT O
delE3 NOUN B-AC
) PUNCT O
, PUNCT O
duplication NOUN O
of ADP O
exon NOUN O
6 NUM O
( PUNCT O
duplE6 NOUN O
) PUNCT O
, PUNCT O
and CCONJ O
wild ADJ O
type NOUN O
allele NOUN O
( PUNCT O
WT NOUN O
) PUNCT O
. PUNCT O
Allele PROPN O
1 NUM O
; PUNCT O
maternal ADJ O
allele NOUN O
, PUNCT O
Allele PROPN O
2 NUM O
, PUNCT O
paternal ADJ O
allele NOUN O
( PUNCT O
see VERB O
S2 PROPN O
Fig PROPN O
) PUNCT O
. PUNCT O

Abbreviations NOUN O
: PUNCT O
HOMA PROPN B-AC
- PUNCT B-AC
IR PROPN B-AC
, PUNCT O
HOMA PROPN O
Insulin PROPN B-LF
Resistance PROPN I-LF
Index PROPN O
; PUNCT O
ESS PROPN B-AC
, PUNCT O
Epworth PROPN B-LF
Sleepiness PROPN I-LF
Scale PROPN I-LF
; PUNCT O
MSLT PROPN B-AC
, PUNCT O
multiple ADJ O
sleep NOUN O
latency NOUN O
test NOUN O
; PUNCT O
TST PROPN B-AC
, PUNCT O
total ADJ B-LF
sleep NOUN I-LF
time NOUN I-LF
; PUNCT O
SOL PROPN B-AC
, PUNCT O
sleep NOUN B-LF
onset NOUN I-LF
latency NOUN I-LF
; PUNCT O
WASO PROPN B-AC
, PUNCT O
waking VERB B-LF
after ADP I-LF
sleep NOUN I-LF
onset NOUN I-LF
; PUNCT O
REM PROPN B-AC
, PUNCT O
rapid ADJ B-LF
eyes NOUN I-LF
movement NOUN I-LF
; PUNCT O
AHI PROPN B-AC
, PUNCT O
apnea NOUN O
- PUNCT O
hypopnea NOUN O
index NOUN O
. PUNCT O

In ADP O
this DET O
study NOUN O
, PUNCT O
the DET B-LF
peel NOUN I-LF
of ADP I-LF
green ADJ I-LF
fruit NOUN I-LF
( PUNCT O
GFP PROPN B-AC
) PUNCT O
, PUNCT O
the DET B-LF
sarcocarp NOUN I-LF
of ADP I-LF
green ADJ I-LF
fruit NOUN I-LF
( PUNCT O
GFS PROPN B-AC
) PUNCT O
, PUNCT O
the DET B-LF
peel NOUN I-LF
of ADP I-LF
red ADJ I-LF
fruit NOUN I-LF
( PUNCT O
FP PROPN B-AC
) PUNCT O
and CCONJ O
the DET B-LF
sarcocarp NOUN I-LF
of ADP I-LF
red ADJ I-LF
fruit NOUN I-LF
( PUNCT O
FS PROPN B-AC
) PUNCT O
of ADP O
G. PROPN O
jasminoides NOUN O
were AUX O
used VERB O
for ADP O
transcriptome NOUN O
sequencing NOUN O
. PUNCT O

Studies NOUN O
show VERB O
that SCONJ O
in ADP O
chronic ADJ O
liver NOUN O
disease NOUN O
, PUNCT O
proinflammatory ADJ O
cytokines NOUN O
such ADJ O
as ADP O
TNF PROPN B-AC
- PUNCT B-AC
α NOUN B-AC
, PUNCT O
IL-1β NOUN O
and CCONJ O
PDGF PROPN B-AC
( PUNCT O
platelet NOUN B-LF
- PUNCT I-LF
derived VERB I-LF
growth NOUN I-LF
factor NOUN I-LF
) PUNCT O
stimulate VERB O
the DET O
secretion NOUN O
of ADP O
SDF-1 NOUN B-AC
by ADP O
hepatocytes NOUN O
in ADP O
the DET O
tissue NOUN O
[ PUNCT O
20,21 NUM O
] PUNCT O
. PUNCT O

Atomic ADJ O
coordinates NOUN O
and CCONJ O
structure NOUN O
factors NOUN O
were AUX O
deposited VERB O
in ADP O
the DET O
Protein PROPN B-LF
Data PROPN I-LF
Bank PROPN I-LF
under ADP O
PDB PROPN B-AC
i NOUN O
d NOUN O
code NOUN O
5HSA NOUN O
. PUNCT O

The DET O
RNA NOUN O
mimic NOUN O
we PRON O
utilized VERB O
comprises VERB O
the DET O
ITS1 PROPN O
sequence NOUN O
, PUNCT O
which PRON O
forms VERB O
the DET O
main ADJ O
binding VERB O
site NOUN O
between ADP O
Rrp5 NOUN O
and CCONJ O
preribosomes NOUN O
( PUNCT O
S1B PROPN O
Fig PROPN O
, PUNCT O
[ NUM O
12,13 NUM O
] PUNCT O
) PUNCT O
. PUNCT O
3 NUM B-AC
- PUNCT B-AC
D NOUN B-AC
reconstruction NOUN O
of ADP O
the DET O
density NOUN O
observed VERB O
for ADP O
the DET O
complex NOUN O
between ADP O
Rrp5 NOUN O
and CCONJ O
RNA NOUN O
( PUNCT O
Rrp5•RNA NOUN B-AC
) PUNCT O
( PUNCT O
EM PROPN B-AC
Database PROPN O
code NOUN O
6655 NUM O
) PUNCT O
shows VERB O
an DET O
elongated ADJ O
molecule NOUN O
with ADP O
a DET O
round ADJ O
, PUNCT O
hollow ADJ O
fist NOUN O
- PUNCT O
like ADJ O
base NOUN O
and CCONJ O
a DET O
slender ADJ O
thumb NOUN O
- PUNCT O
like ADJ O
projection NOUN O
( PUNCT O
Fig PROPN O
4B NUM O
) PUNCT O
. PUNCT O
2 NUM B-AC
- PUNCT B-AC
D NOUN B-AC
alignment NOUN O
and CCONJ O
classification NOUN O
and CCONJ O
3 NUM B-AC
- PUNCT B-AC
D NOUN B-AC
analysis NOUN O
by ADP O
random ADJ B-LF
conical ADJ I-LF
tilt NOUN I-LF
( PUNCT O
RCT PROPN B-AC
) PUNCT O
confirm VERB O
this DET O
assessment NOUN O
( PUNCT O
S5 PROPN O
Fig PROPN O
) PUNCT O
. PUNCT O

At ADP O
24 NUM O
hpi NOUN B-AC
, PUNCT O
we PRON O
euthanized VERB O
embryos NOUN O
and CCONJ O
determined VERB O
bacterial ADJ O
burden NOUN O
( PUNCT O
colony NOUN B-LF
- PUNCT I-LF
forming VERB I-LF
units NOUN I-LF
[ PUNCT O
CFU PROPN B-AC
] PUNCT O
) PUNCT O
in ADP O
whole ADJ O
fish NOUN O
. PUNCT O

In ADP O
our PRON O
expedition NOUN O
to ADP O
characterize VERB O
membrane NOUN O
biogenesis NOUN O
in ADP O
T. PROPN O
gondii PROPN O
, PUNCT O
we PRON O
fractionated VERB O
the DET O
parasite NOUN O
lipids NOUN O
by ADP O
high ADJ O
- PUNCT O
performance NOUN O
liquid NOUN O
chromatography NOUN O
( PUNCT O
HPLC PROPN B-AC
) PUNCT O
and CCONJ O
observed VERB O
a DET O
major ADJ O
lipid NOUN O
peak NOUN O
X1 NUM O
eluting VERB O
next ADV O
to ADP O
PtdSer PROPN B-AC
( PUNCT O
Fig PROPN O
1A NUM O
) PUNCT O
. PUNCT O
Other ADJ O
major ADJ O
lipids NOUN O
were AUX O
PtdCho PROPN B-AC
, PUNCT O
PtdEtn PROPN B-AC
, PUNCT O
PtdIns PROPN B-AC
, PUNCT O
PtdSer PROPN B-AC
, PUNCT O
and CCONJ O
phosphoethanolamine NOUN B-LF
- PUNCT I-LF
ceramide NOUN I-LF
( PUNCT O
PEtn PROPN B-AC
- PUNCT B-AC
Cer PROPN B-AC
) PUNCT O
, PUNCT O
confirming VERB O
previous ADJ O
reports NOUN O
[ X O
5,7 NUM O
] PUNCT O
. PUNCT O

The DET O
first ADJ O
layer NOUN O
line NOUN O
indicates VERB O
the DET O
111 NUM O
- PUNCT O
Å NOUN O
helical ADJ O
pitch NOUN O
of ADP O
the DET O
WT PROPN B-AC
- PUNCT B-AC
M1 PROPN B-AC
oligomer NOUN O
. PUNCT O
( PUNCT O
C NOUN O
) PUNCT O
2D ADJ O
class NOUN O
averages NOUN O
that PRON O
focus VERB O
on ADP O
the DET O
center NOUN O
of ADP O
the DET O
helical ADJ O
segments NOUN O
show VERB O
large ADJ O
heterogeneity NOUN O
of ADP O
additional ADJ O
density NOUN O
on ADP O
either DET O
side NOUN O
of ADP O
the DET O
outer ADJ O
layer NOUN O
of ADP O
the DET O
filament NOUN O
. PUNCT O
cryo ADJ B-AC
- PUNCT B-AC
EM PROPN B-AC
, PUNCT O
cryo ADJ B-LF
- PUNCT I-LF
electron NOUN I-LF
microscopy NOUN I-LF
; PUNCT O
M1 PROPN B-AC
, PUNCT O
matrix NOUN B-LF
protein NOUN I-LF
1 NUM I-LF
; PUNCT O
WT PROPN B-AC
- PUNCT B-AC
M1 PROPN B-AC
, PUNCT O
full ADJ B-LF
- PUNCT I-LF
length NOUN I-LF
PR8 PROPN I-LF
M1 PROPN I-LF
. PUNCT O

HP PROPN B-AC
, PUNCT O
hippocampus NOUN B-LF
; PUNCT O
LEC PROPN B-AC
, PUNCT O
lateral ADJ B-LF
entorhinal ADJ I-LF
cortex NOUN I-LF
; PUNCT O
MTC PROPN B-AC
, PUNCT O
mitral ADJ B-LF
and CCONJ I-LF
tufted ADJ I-LF
cell NOUN I-LF
; PUNCT O
OB PROPN B-AC
, PUNCT O
olfactory ADJ B-LF
bulb NOUN I-LF
; PUNCT O
PFC PROPN B-AC
, PUNCT O
prefrontal ADJ B-LF
cortex NOUN I-LF
; PUNCT O
RR NOUN B-AC
, PUNCT O
respiration NOUN B-LF
- PUNCT I-LF
related VERB I-LF
rhythm NOUN I-LF
. PUNCT O

The DET O
histone NOUN B-LF
deacetylase NOUN I-LF
1 NUM I-LF
( PUNCT O
HDAC1 NOUN B-AC
) PUNCT O
was AUX O
used VERB O
as ADP O
a DET O
loading NOUN O
control NOUN O
. PUNCT O

In ADP O
the DET O
models NOUN O
presented VERB O
here ADV O
, PUNCT O
weight NOUN B-LF
- PUNCT I-LF
for ADP I-LF
- PUNCT I-LF
length NOUN I-LF
- PUNCT I-LF
z NOUN I-LF
- PUNCT I-LF
scores NOUN I-LF
( PUNCT O
WLZs NOUN B-AC
) PUNCT O
were AUX O
used VERB O
. PUNCT O

In ADP O
order NOUN O
to PART O
identify VERB O
essential ADJ O
genes NOUN O
on ADP O
the DET O
X NOUN O
chromosome NOUN O
that PRON O
are AUX O
involved ADJ O
in ADP O
neuronal ADJ O
homeostasis NOUN O
, PUNCT O
we PRON O
performed VERB O
a DET O
forward ADJ O
genetic ADJ O
screen NOUN O
using VERB O
ethyl NOUN B-LF
methanesulfonate NOUN I-LF
( PUNCT O
EMS PROPN B-AC
) PUNCT O
. PUNCT O
We PRON O
used VERB O
the DET O
FLP PROPN O
/ SYM O
FRT PROPN O
system NOUN O
to PART O
induce VERB O
homozygous ADJ O
mutant ADJ O
clones NOUN O
in ADP O
the DET O
photoreceptor NOUN O
neurons NOUN O
of ADP O
the DET O
otherwise ADV O
heterozygous ADJ O
flies NOUN O
and CCONJ O
performed VERB O
electroretinograms NOUN B-LF
( PUNCT O
ERGs PROPN B-AC
) PUNCT O
on ADP O
3- NUM O
and CCONJ O
33 NUM O
- PUNCT O
days NOUN O
- PUNCT O
old ADJ O
flies NOUN O
. PUNCT O

Secondary ADJ O
results NOUN O
included VERB O
spherical ADJ B-LF
equivalent NOUN I-LF
( PUNCT O
SE PROPN B-AC
) PUNCT O
and CCONJ O
CCT PROPN B-AC
. PUNCT O
Finally ADV O
, PUNCT O
ECD PROPN B-AC
and CCONJ O
IOP PROPN O
were AUX O
set VERB O
as ADP O
the DET O
last ADJ O
observation NOUN O
indicator NOUN O
to PART O
evaluate VERB O
the DET O
safety NOUN O
of ADP O
surgery NOUN O
. PUNCT O

HILIC PROPN B-AC
- PUNCT B-AC
MS2 PROPN B-AC
of ADP O
stereo ADV O
- PUNCT O
controlled VERB O
β NOUN B-AC
- PUNCT B-AC
GlcCer PROPN B-AC
and CCONJ O
an DET O
α NOUN O
/ SYM O
β NOUN B-AC
- PUNCT B-AC
GlcCer PROPN B-AC
mixture NOUN O
. PUNCT O
α NOUN O
/ SYM O
β NOUN B-AC
- PUNCT B-AC
GlcCer PROPN B-AC
, PUNCT O
α NOUN O
/ SYM O
β NOUN B-LF
- PUNCT I-LF
glucosylceramide NOUN I-LF
; PUNCT O
HILIC PROPN B-AC
- PUNCT B-AC
MS2 PROPN B-AC
, PUNCT O
hydrophilic ADJ B-LF
interaction NOUN I-LF
liquid NOUN I-LF
chromatography NOUN I-LF
- PUNCT I-LF
tandem NOUN I-LF
mass NOUN I-LF
spectrometry NOUN I-LF
. PUNCT O

COTS PROPN B-AC
, PUNCT O
crown NOUN B-LF
- PUNCT I-LF
of ADP I-LF
- PUNCT I-LF
thorns NOUN I-LF
starfish NOUN I-LF
; PUNCT O
GBR PROPN B-AC
, PUNCT O
Great PROPN B-LF
Barrier PROPN I-LF
Reef PROPN I-LF
; PUNCT O
NCJ PROPN O
, PUNCT O
North PROPN O
Caledonian PROPN O
Jet PROPN O
; PUNCT O
SCJ PROPN O
, PUNCT O
South PROPN O
Caledonian PROPN O
Jet PROPN O
. PUNCT O

We PRON O
mechanistically ADV O
studied VERB O
tTreg NOUN B-AC
cell NOUN O
generation NOUN O
in ADP O
the DET O
atrophied ADJ O
thymus NOUN O
by ADP O
utilizing VERB O
both CCONJ O
postnatal ADJ O
TEC NOUN B-AC
- PUNCT O
defective ADJ O
( PUNCT O
resulting VERB O
from ADP O
FoxN1 PROPN B-AC
- PUNCT O
floxed VERB O
conditional ADJ B-LF
knockout NOUN I-LF
[ X O
cKO NOUN B-AC
] PUNCT O
) PUNCT O
and CCONJ O
naturally ADV O
aged VERB O
mouse NOUN O
models NOUN O
. PUNCT O

A DET O
switch NOUN O
of ADP O
this DET O
balance NOUN O
to ADP O
the DET O
benefit NOUN O
of ADP O
augmented VERB O
responses NOUN O
toward ADP O
TGFβ NOUN B-AC
is AUX O
a DET O
hallmark NOUN O
of ADP O
endothelial ADJ B-LF
cell NOUN I-LF
( PUNCT O
EC PROPN B-AC
) PUNCT O
dysfunction NOUN O
and CCONJ O
precondition NOUN O
to ADP O
several ADJ O
vascular ADJ O
diseases NOUN O
, PUNCT O
including VERB O
cerebral ADJ B-LF
cavernous ADJ I-LF
malformation NOUN I-LF
( PUNCT O
CCM PROPN B-AC
) PUNCT O
[ PUNCT O
2 NUM O
] PUNCT O
, PUNCT O
hereditary ADJ B-LF
hemorrhagic ADJ I-LF
telangiectasia NOUN I-LF
( PUNCT O
HHT PROPN B-AC
) PUNCT O
[ PUNCT O
3 NUM O
] PUNCT O
, PUNCT O
and CCONJ O
pulmonary ADJ B-LF
arterial ADJ I-LF
hypertension NOUN I-LF
( PUNCT O
PAH PROPN B-AC
) PUNCT O
. PUNCT O
Understanding VERB O
the DET O
cellular ADJ O
context NOUN O
in ADP O
which PRON O
this DET O
imbalance NOUN O
takes VERB O
place NOUN O
is AUX O
key ADJ O
to ADP O
tackling VERB O
augmented VERB O
TGFβ NOUN B-AC
signaling NOUN O
[ PUNCT O
4 NUM O
] PUNCT O
. PUNCT O

ACE2 PROPN B-AC
, PUNCT O
angiotensin NOUN B-LF
- PUNCT I-LF
converting VERB I-LF
enzyme NOUN I-LF
2 NUM I-LF
; PUNCT O
RBD PROPN B-AC
, PUNCT O
receptor NOUN B-LF
binding VERB I-LF
domain NOUN I-LF
; PUNCT O
SARS PROPN B-AC
- PUNCT B-AC
CoV-2 PROPN B-AC
, PUNCT O
SARS PROPN B-LF
Coronavirus PROPN I-LF
2 NUM I-LF
. PUNCT O

CIDRZ PROPN B-AC
, PUNCT O
Centre PROPN B-LF
for ADP I-LF
Infectious PROPN I-LF
Disease PROPN I-LF
Research PROPN I-LF
in ADP I-LF
Zambia PROPN I-LF
; PUNCT O
LTFU PROPN O
, PUNCT O
lost VERB O
to ADP O
follow NOUN O
- PUNCT O
up NOUN O
; PUNCT O
PPS PROPN O
, PUNCT O
probability NOUN O
proportional ADJ O
to ADP O
size NOUN O
; PUNCT O
SRS PROPN O
, PUNCT O
simple ADJ O
random ADJ O
sample NOUN O
. PUNCT O

Thoracolumbar ADJ B-LF
interfascial ADJ I-LF
block NOUN I-LF
( PUNCT O
TLIP NOUN B-AC
block NOUN B-AC
) PUNCT O
is AUX O
a DET O
novel ADJ O
regional ADJ O
anesthesia NOUN O
technique NOUN O
first ADV O
described VERB O
by ADP O
Hand PROPN O
et NOUN O
al NOUN O
. PUNCT O
in ADP O
2015 NUM O
[ PUNCT O
7 NUM O
] PUNCT O
, PUNCT O
which PRON O
is AUX O
an DET O
interfascial ADJ O
plane NOUN O
block NOUN O
applied VERB O
at ADP O
the DET O
L3 NOUN O
vertebral ADJ O
level NOUN O
in ADP O
spine NOUN O
surgery NOUN O
. PUNCT O

Abbreviations NOUN O
: PUNCT O
ACE PROPN B-AC
, PUNCT O
adverse ADJ B-LF
childhood NOUN I-LF
experience NOUN I-LF
; PUNCT O
CI PROPN B-AC
, PUNCT O
confidence NOUN B-LF
interval NOUN I-LF
; PUNCT O
CSE PROPN O
, PUNCT O
Certificate PROPN O
of ADP O
Secondary PROPN O
Education PROPN O
; PUNCT O
GCSE PROPN B-AC
, PUNCT O
General PROPN B-LF
Certificate PROPN I-LF
of ADP I-LF
Secondary PROPN I-LF
Education PROPN I-LF
; PUNCT O
PAF PROPN O
, PUNCT O
population NOUN O
attributable ADJ O
fraction NOUN O
; PUNCT O
RD PROPN B-AC
, PUNCT O
risk NOUN B-LF
difference NOUN I-LF
. PUNCT O

BMI NOUN B-AC
= VERB O
body NOUN B-LF
mass NOUN I-LF
index NOUN I-LF
; PUNCT O
MET PROPN B-AC
= VERB O
metabolic ADJ B-LF
equivalent NOUN I-LF

Isolates NOUN O
were AUX O
cultured VERB O
from ADP O
sputum NOUN O
or CCONJ O
bronchoalveolar ADJ B-LF
lavage NOUN I-LF
( PUNCT O
BAL NOUN B-AC
) PUNCT O
from ADP O
patients NOUN O
with ADP O
CF PROPN B-AC
after ADP O
obtaining VERB O
informed ADJ O
consent NOUN O
. PUNCT O

Reviewer ADJ O
comment NOUN O
: PUNCT O
13 X O
. X O
“ PUNCT O
Table NOUN O
4 NUM O
: PUNCT O
Bivariate ADJ O
and CCONJ O
Multivariate ADJ O
analysis NOUN O
on ADP O
treatment NOUN O
outcome NOUN O
of ADP O
SAM PROPN B-AC
and CCONJ O
associated VERB O
factors NOUN O
” PUNCT O
shall AUX O
be AUX O
re VERB O
- VERB O
written VERB O
as ADP O
“ PUNCT O
Table NOUN O
4 NUM O
: PUNCT O
Treatment NOUN O
outcome NOUN O
of ADP O
severe ADJ B-LF
acute ADJ I-LF
malnutrition NOUN I-LF
and CCONJ O
associated VERB O
factors NOUN O
in ADP O
------ PUNCT O
Woreda PROPN O
, PUNCT O
Northern PROPN O
Wollo PROPN O
, PUNCT O
Ethiopia PROPN O
---month NOUN O
, PUNCT O
----year NOUN O
to ADP O
-----month NOUN O
, PUNCT O
----year NOUN O
” PUNCT O

Dual ADJ B-LF
- PUNCT I-LF
specificity NOUN I-LF
tyrosine NOUN I-LF
- PUNCT I-LF
phosphorylation NOUN I-LF
- PUNCT I-LF
regulated VERB I-LF
kinase NOUN I-LF
2 NUM I-LF
( PUNCT O
DYRK2 PROPN B-AC
) PUNCT O
is AUX O
a DET O
member NOUN O
of ADP O
dual ADJ O
- PUNCT O
specificity NOUN O
kinase NOUN O
family NOUN O
, PUNCT O
which PRON O
could AUX O
phosphorylate VERB O
both CCONJ O
Ser PROPN O
/ SYM O
Thr PROPN O
and CCONJ O
Tyr PROPN O
substrates NOUN O
. PUNCT O

Damage NOUN B-LF
- PUNCT I-LF
associated VERB I-LF
molecular ADJ I-LF
patterns NOUN I-LF
( PUNCT O
DAMPs PROPN B-AC
) PUNCT O
are AUX O
released VERB O
into ADP O
the DET O
extracellular ADJ O
space NOUN O
by ADP O
tissue NOUN O
damage NOUN O
that PRON O
triggers VERB O
an DET O
inflammatory ADJ O
response NOUN O
without ADP O
infection NOUN O
. PUNCT O

Other ADJ O
outcomes NOUN O
included VERB O
weight NOUN O
gain NOUN O
velocity NOUN O
after ADP O
two NUM O
weeks NOUN O
, PUNCT O
length NOUN B-LF
of ADP I-LF
stay NOUN I-LF
( PUNCT O
LoS PROPN B-AC
) PUNCT O
, PUNCT O
discharge NOUN O
anthropometrics NOUN O
, PUNCT O
linear ADJ O
and CCONJ O
MUAC PROPN B-AC
growth NOUN O
, PUNCT O
treatment NOUN O
outcome NOUN O
, PUNCT O
morbidity NOUN O
, PUNCT O
and CCONJ O
relapses NOUN O
. PUNCT O

PRISMA PROPN B-AC
, PUNCT O
Preferred ADJ B-LF
Reporting NOUN I-LF
Items NOUN I-LF
for ADP I-LF
Systematic ADJ I-LF
Reviews NOUN I-LF
and CCONJ I-LF
Meta NOUN I-LF
- NOUN I-LF
Analyses NOUN I-LF
. PUNCT O

Although SCONJ O
the DET O
phosphorylation NOUN O
of ADP O
eIF2α NOUN B-AC
leads VERB O
to ADP O
attenuation NOUN O
of ADP O
the DET O
translation NOUN O
of ADP O
most ADJ O
transcripts NOUN O
, PUNCT O
it PRON O
also ADV O
increases VERB O
the DET O
translation NOUN O
of ADP O
specific ADJ O
mRNAs NOUN O
such ADJ O
as ADP O
activating VERB B-LF
transcription NOUN I-LF
factor NOUN I-LF
4 NUM I-LF
( PUNCT O
ATF4 PROPN B-AC
) PUNCT O
[ X O
41 NUM O
] X O
as ADP O
part NOUN O
of ADP O
the DET O
stress NOUN O
response NOUN O
. PUNCT O

Bradykinin NOUN B-LF
( PUNCT O
BK)-related PROPN B-AC
peptides NOUN O
, PUNCT O
derived VERB O
from ADP O
the DET O
selective ADJ O
cleavage NOUN O
of ADP O
circulating VERB O
kininogens NOUN O
, PUNCT O
stimulate VERB O
two NUM O
related ADJ O
G PROPN O
protein NOUN O
coupled VERB O
receptors NOUN O
: PUNCT O
the DET O
widely ADV O
expressed VERB O
BK PROPN B-AC
B2 PROPN B-LF
receptor NOUN I-LF
( PUNCT O
B2R NOUN B-AC
) PUNCT O
and CCONJ O
the DET O
strongly ADV O
regulated VERB O
B1 PROPN B-LF
receptor NOUN I-LF
( PUNCT O
B1R NOUN B-AC
) PUNCT O
[ PUNCT O
1 NUM O
] PUNCT O
. PUNCT O

• PUNCT O
LC PROPN B-AC
is AUX O
not PART O
a DET O
common ADJ O
abbreviation NOUN O
; PUNCT O
I PRON O
suggest VERB O
to PART O
write VERB O
liver NOUN B-LF
cirrhosis NOUN I-LF
in ADP O
full ADJ O
throughout ADP O
. PUNCT O

AAA PROPN B-AC
, PUNCT O
abdominal ADJ B-LF
aortic ADJ I-LF
aneurysm NOUN I-LF
; PUNCT O
Ang PROPN B-AC
II NUM B-AC
, PUNCT O
angiotensin NOUN B-LF
II NUM I-LF
; PUNCT O
Drp1 PROPN B-AC
, PUNCT O
dynamin NOUN B-LF
- PUNCT I-LF
related VERB I-LF
protein NOUN I-LF
1 NUM I-LF
; PUNCT O
Mdivi-1 PROPN B-AC
, PUNCT O
mitochondrial ADJ B-LF
division NOUN I-LF
inhibitor NOUN I-LF
1 NUM I-LF
; PUNCT O
Mfn1 PROPN B-AC
, PUNCT O
mitofusin NOUN B-LF
1 NUM I-LF
; PUNCT O
MTG PROPN B-AC
, PUNCT O
MitoTracker PROPN B-LF
Green PROPN I-LF
; PUNCT O
mtROS PROPN B-AC
, PUNCT O
mitochondrial ADJ B-LF
ROS NOUN I-LF
; PUNCT O
si PROPN O
- PUNCT O
Drp1 PROPN B-AC
, PUNCT O
short ADJ O
interfering VERB O
RNA NOUN O
targeting VERB O
Drp1 PROPN B-AC
; PUNCT O
si PROPN O
- PUNCT O
NC PROPN O
, PUNCT O
short ADJ O
interfering VERB O
RNA NOUN O
control NOUN O
; PUNCT O
VSMC PROPN B-AC
, PUNCT O
vascular ADJ B-LF
smooth ADJ I-LF
muscle NOUN I-LF
cell NOUN I-LF
. PUNCT O

Stimulus NOUN B-LF
- PUNCT I-LF
specific ADJ I-LF
adaptation NOUN I-LF
( PUNCT O
SSA PROPN B-AC
) PUNCT O
in ADP O
single ADJ O
neurons NOUN O
of ADP O
the DET O
auditory ADJ O
cortex NOUN O
was AUX O
suggested VERB O
to PART O
be AUX O
a DET O
potential ADJ O
neural ADJ O
correlate NOUN O
of ADP O
the DET O
mismatch NOUN B-LF
negativity NOUN I-LF
( PUNCT O
MMN PROPN B-AC
) PUNCT O
, PUNCT O
a DET O
widely ADV O
studied ADJ O
component NOUN O
of ADP O
the DET O
auditory ADJ O
event NOUN B-LF
- PUNCT I-LF
related VERB I-LF
potentials NOUN I-LF
( PUNCT O
ERP PROPN B-AC
) PUNCT O
that PRON O
is AUX O
elicited VERB O
by ADP O
changes NOUN O
in ADP O
the DET O
auditory ADJ O
environment NOUN O
. PUNCT O

One NUM O
identified VERB O
candidate NOUN O
for ADP O
asparagine NOUN O
hydroxylation NOUN O
was AUX O
the DET O
deubiquitinase NOUN B-LF
( PUNCT O
DUB PROPN B-AC
) PUNCT O
ovarian ADJ B-LF
tumor NOUN I-LF
domain NOUN I-LF
containing VERB I-LF
ubiquitin NOUN I-LF
aldehyde NOUN I-LF
binding VERB I-LF
protein NOUN I-LF
1 NUM I-LF
( PUNCT O
OTUB1 PROPN B-AC
) PUNCT O
( PUNCT O
Uniprot PROPN O
accession NOUN O
number NOUN O
: PUNCT O
Q96FW1 PROPN O
) PUNCT O
[ PUNCT O
19 NUM O
] PUNCT O
. PUNCT O

These DET O
visits NOUN O
are AUX O
augmented VERB O
by ADP O
visits NOUN O
from ADP O
the DET O
volunteer NOUN O
community NOUN O
health NOUN O
workers NOUN O
( PUNCT O
Shasthya PROPN B-LF
Shebika PROPN I-LF
[ PUNCT O
SSs PROPN B-AC
] PUNCT O
) PUNCT O
, PUNCT O
a DET O
cadre NOUN O
chosen VERB O
from ADP O
and CCONJ O
by ADP O
their PRON O
communities NOUN O
who PRON O
receive VERB O
a DET O
15 NUM O
- PUNCT O
day NOUN O
training NOUN O
course NOUN O
followed VERB O
by ADP O
monthly ADJ O
refresher NOUN O
training NOUN O
and CCONJ O
ad X O
hoc X O
3 NUM O
- PUNCT O
day NOUN O
intensive ADJ O
training NOUN O
for ADP O
new ADJ O
content NOUN O
areas NOUN O
. PUNCT O

CI PROPN B-AC
, PUNCT O
confidence NOUN B-LF
interval NOUN I-LF
; PUNCT O
DNI PROPN B-AC
, PUNCT O
delta NOUN B-LF
neutrophil NOUN I-LF
index NOUN I-LF
; PUNCT O
SOFA PROPN B-AC
, PUNCT O
sequential ADJ B-LF
organ NOUN I-LF
failure NOUN I-LF
assessment NOUN I-LF
; PUNCT O
POD1 PROPN O
, PUNCT O
postoperative ADJ O
day NOUN O
1 NUM O
; PUNCT O
ICU PROPN B-AC
, PUNCT O
intensive ADJ B-LF
care NOUN I-LF
unit NOUN I-LF
. PUNCT O

It PRON O
was AUX O
shown VERB O
previously ADV O
that SCONJ O
antiviral ADJ O
RNAi NOUN B-AC
in ADP O
honey NOUN O
bees NOUN O
could AUX O
be AUX O
induced VERB O
by ADP O
introduction NOUN O
of ADP O
double ADJ B-LF
- PUNCT I-LF
stranded ADJ I-LF
RNA NOUN I-LF
( PUNCT O
dsRNA NOUN B-AC
) PUNCT O
molecules NOUN O
orally ADV O
[ X O
30 NUM O
] PUNCT O
. PUNCT O

In ADP O
the DET O
Leiden PROPN B-LF
Thrombophilia PROPN I-LF
Study PROPN I-LF
( PUNCT O
LETS PROPN B-AC
) PUNCT O
, PUNCT O
both CCONJ O
cytokines NOUN O
and CCONJ O
tumour NOUN B-LF
necrosis NOUN I-LF
factor NOUN I-LF
alpha NOUN I-LF
( PUNCT O
TNF PROPN B-AC
- ADJ B-AC
α NOUN B-AC
) PUNCT O
were AUX O
associated VERB O
with ADP O
a DET O
2- NUM O
to PART O
3 NUM O
- ADJ O
fold ADJ O
increased VERB O
risk NOUN O
of ADP O
a DET O
first ADJ O
VT PROPN B-AC
, PUNCT O
whereas SCONJ O
the DET O
risk NOUN O
for ADP O
IL-10 NOUN B-AC
seemed VERB O
to PART O
be AUX O
decreased VERB O
[ PUNCT O
17 NUM O
] PUNCT O
. PUNCT O

In ADP O
93/255 NUM O
( PUNCT O
36 NUM O
% NOUN O
) PUNCT O
non ADJ O
- ADJ O
Cochrane PROPN O
SRs NOUN B-AC
, PUNCT O
authors NOUN O
reported VERB O
using VERB O
Cochrane PROPN O
methods NOUN O
( PUNCT O
e.g. X O
, PUNCT O
cited VERB O
the DET O
Cochrane PROPN O
Handbook PROPN O
for ADP O
Systematic PROPN B-LF
Reviews PROPN I-LF
of ADP O
Interventions PROPN O
[ PUNCT O
19 NUM O
] PUNCT O
) PUNCT O
. PUNCT O

PDB PROPN B-AC
, PUNCT O
Protein PROPN B-LF
Data PROPN I-LF
Bank PROPN I-LF
; PUNCT O
RSVF PROPN B-AC
, PUNCT O
respiratory ADJ O
syncytial ADJ O
virus NOUN O
fusion NOUN O
protein NOUN O
; PUNCT O
SASA PROPN O
, PUNCT O
solvent NOUN O
accessible ADJ O
surface NOUN O
area NOUN O
. PUNCT O

CBA PROPN O
: PUNCT O
cytometric ADJ O
bead NOUN O
array NOUN O
; PUNCT O
CDS PROPN B-AC
: PUNCT O
clinical ADJ B-LF
disease NOUN I-LF
score NOUN I-LF
; PUNCT O
CLP PROPN B-AC
: PUNCT O
caecal NOUN B-LF
ligation NOUN I-LF
and CCONJ I-LF
puncture NOUN I-LF
; PUNCT O
MLN NOUN B-AC
: PUNCT O
mesenteric ADJ B-LF
lymph NOUN I-LF
nodes NOUN I-LF
; PUNCT O
mRNA NOUN O
: PUNCT O
messenger NOUN O
ribonucleic NOUN O
acid NOUN O
; PUNCT O
RT NOUN O
- PUNCT O
PCR PROPN O
: PUNCT O
reverse ADJ O
transcriptase NOUN O
real ADJ O
- PUNCT O
time NOUN O
polymerase NOUN O
chain NOUN O
reaction NOUN O
. PUNCT O

Recently ADV O
, PUNCT O
the DET O
gene NOUN O
family NOUN O
arylamine NOUN B-LF
N NOUN I-LF
- NOUN I-LF
acetyltransferases NOUN I-LF
( PUNCT O
NATs NOUN B-AC
) PUNCT O
, PUNCT O
which PRON O
is AUX O
another DET O
phase NOUN O
II NUM O
enzyme NOUN O
has AUX O
been AUX O
shown VERB O
to PART O
be AUX O
phylogenetically ADV O
unstable ADJ O
too ADV O
[ PUNCT O
7 NUM O
] PUNCT O
. PUNCT O

microRNAs NOUN B-LF
( PUNCT O
miRNAs NOUN B-AC
) PUNCT O
are AUX O
important ADJ O
post ADJ O
- ADJ O
transcriptional ADJ O
regulators NOUN O
, PUNCT O
but CCONJ O
the DET O
extent NOUN O
of ADP O
this DET O
regulation NOUN O
is AUX O
uncertain ADJ O
, PUNCT O
both PRON O
with ADP O
regard NOUN O
to ADP O
the DET O
number NOUN O
of ADP O
miRNA NOUN B-AC
genes NOUN O
and CCONJ O
their PRON O
targets NOUN O
. PUNCT O

Top NOUN B-LF
of ADP I-LF
SF NOUN I-LF
or CCONJ I-LF
AS NOUN I-LF

To ADP O
our PRON O
knowledge NOUN O
, PUNCT O
this PRON O
is AUX O
the DET O
most ADV O
diversified ADJ O
and CCONJ O
comprehensive ADJ O
panel NOUN O
of ADP O
clinical ADJ O
and CCONJ O
genotype NOUN O
specimens NOUN O
used VERB O
in ADP O
HCV NOUN B-AC
nucleic NOUN B-LF
acid NOUN I-LF
testing NOUN I-LF
( PUNCT O
NAT PROPN B-AC
) PUNCT O
validation NOUN O
to ADP O
date NOUN O
. PUNCT O

Parents NOUN O
completed VERB O
the DET O
Behavior PROPN B-LF
Assessment PROPN I-LF
System PROPN I-LF
for ADP I-LF
Children PROPN I-LF
, PUNCT I-LF
Second PROPN I-LF
Edition PROPN I-LF
( PUNCT O
BASC-2 PROPN B-AC
) PUNCT O
[ PUNCT O
27 NUM O
] PUNCT O
, PUNCT O
and CCONJ O
the DET O
Behavior PROPN B-LF
Rating PROPN I-LF
Inventory PROPN I-LF
of ADP I-LF
Executive PROPN I-LF
Function PROPN I-LF
( PUNCT O
BRIEF PROPN B-AC
) PUNCT O
[ PUNCT O
28 NUM O
] PUNCT O
. PUNCT O

Interestingly ADV O
, PUNCT O
one NUM O
group NOUN O
reported VERB O
that SCONJ O
the DET O
prostate NOUN B-LF
apoptosis NOUN I-LF
response NOUN I-LF
4 NUM I-LF
( PUNCT O
PAR-4 NOUN B-AC
) PUNCT O
, PUNCT O
a DET O
substrate NOUN O
of ADP O
ZIPK PROPN B-AC
, PUNCT O
is AUX O
capable ADJ O
of ADP O
translocating VERB O
ZIPK PROPN B-AC
from ADP O
the DET O
PODs NOUN B-AC
to ADP O
the DET O
actin NOUN O
microfilaments NOUN O
[ X O
4,12,13 NUM O
] PUNCT O
. PUNCT O

BFP PROPN B-AC
, PUNCT O
body NOUN B-LF
fat NOUN I-LF
percentage NOUN I-LF
; PUNCT O
CE PROPN B-AC
, PUNCT O
cholesteryl NOUN B-LF
ester NOUN I-LF
; PUNCT O
Chol PROPN B-AC
, PUNCT O
cholesterol NOUN B-LF
; PUNCT O
DAG PROPN B-AC
, PUNCT O
diacylglyceride NOUN B-LF
; PUNCT O
LPC PROPN B-AC
, PUNCT O
lysophosphatidylcholine NOUN B-LF
; PUNCT O
MAE PROPN B-AC
, PUNCT O
mean ADJ B-LF
absolute ADJ I-LF
error NOUN I-LF
; PUNCT O
PC PROPN B-AC
, PUNCT O
phosphatidylcholine NOUN B-LF
; PUNCT O
PE PROPN B-AC
, PUNCT O
phosphatidylethanolamine NOUN B-LF
; PUNCT O
PI PROPN O
, PUNCT O
phosphatidylinositol NOUN O
; PUNCT O
SM PROPN B-AC
, PUNCT O
sphingomyelin NOUN B-LF
; PUNCT O
TAG PROPN B-AC
, PUNCT O
triacylglyceride NOUN B-LF
. PUNCT O

Expression NOUN O
levels NOUN O
of ADP O
frizzled ADJ O
homolog NOUN O
9 NUM O
( PUNCT O
Fzd9 PROPN O
) PUNCT O
, PUNCT O
calsequestrin NOUN B-LF
2 NUM I-LF
( PUNCT O
Casq2 PROPN B-AC
) PUNCT O
, PUNCT O
potassium NOUN O
large ADJ O
conductance NOUN O
calcium NOUN O
- PUNCT O
activated VERB O
channel NOUN O
, PUNCT O
subfamily NOUN O
M PROPN O
, PUNCT O
alpha NOUN O
member NOUN O
1 NUM O
( PUNCT O
Kcnma1 PROPN O
) PUNCT O
, PUNCT O
peroxisome NOUN O
proliferator NOUN O
activated VERB O
receptor NOUN O
alpha NOUN O
( PUNCT O
Ppara PROPN O
) PUNCT O
, PUNCT O
actinin NOUN O
alpha NOUN O
3 NUM O
( PUNCT O
Actn3 PROPN O
) PUNCT O
, PUNCT O
myogenic NOUN O
factor NOUN O
6 NUM O
( PUNCT O
Myf6 PROPN O
) PUNCT O
, PUNCT O
myostatin NOUN O
( PUNCT O
Mstn PROPN O
) PUNCT O
and CCONJ O
Muscle PROPN O
RING PROPN O
Finger PROPN O
1 NUM O
( PUNCT O
MuRF1 PROPN O
) PUNCT O
were AUX O
evaluated VERB O
by ADP O
real ADJ O
- PUNCT O
time NOUN O
quantitative ADJ O
PCR NOUN O
in ADP O
soleus NOUN O
of ADP O
flown VERB O
( PUNCT O
BF PROPN B-AC
) PUNCT O
and CCONJ O
ground NOUN O
control NOUN O
mice NOUN O
( PUNCT O
BG PROPN B-AC
) PUNCT O
. PUNCT O
Actb PROPN O
( PUNCT O
beta NOUN O
actin NOUN O
) PUNCT O
was AUX O
used VERB O
as ADP O
housekeeping NOUN O
to PART O
calculate VERB O
the DET O
delta NOUN O
Ct NOUN O
of ADP O
the DET O
selected VERB O
genes NOUN O
. PUNCT O

BCI PROPN B-AC
, PUNCT O
brain NOUN B-LF
– PUNCT I-LF
computer NOUN I-LF
interface NOUN I-LF
. PUNCT O

During ADP O
stimulus NOUN O
presentation NOUN O
, PUNCT O
one NUM O
of ADP O
the DET O
following ADJ O
gestures NOUN O
was AUX O
performed VERB O
by ADP O
the DET O
experimenter NOUN O
: PUNCT O
TP NOUN B-AC
, PUNCT O
MO NOUN B-AC
, PUNCT O
LPS NOUN B-AC
, PUNCT O
HO NOUN B-AC
, PUNCT O
or CCONJ O
eyes NOUN B-LF
opening NOUN I-LF
( PUNCT O
EYE NOUN B-AC
, PUNCT O
biological ADJ O
control NOUN O
condition NOUN O
) PUNCT O
. PUNCT O

The DET O
study NOUN O
pharmacist NOUN O
reviewed VERB O
drug NOUN B-LF
- PUNCT I-LF
drug NOUN I-LF
interactions NOUN I-LF
( PUNCT O
DDIs NOUN B-AC
) PUNCT O
, PUNCT O
DGIs NOUN B-AC
, PUNCT O
and CCONJ O
cumulative ADJ O
drug NOUN O
and/or CCONJ O
gene NOUN O
interactions NOUN O
in ADP O
the DET O
tested VERB O
group NOUN O
using VERB O
the DET O
YouScript PROPN O
® NUM O
generated VERB O
reports NOUN O
and CCONJ O
CDST NOUN B-AC
to ADP O
provide VERB O
drug NOUN O
therapy NOUN O
recommendations NOUN O
to ADP O
clinicians NOUN O
, PUNCT O
after ADP O
which PRON O
prescriptions NOUN O
were AUX O
altered VERB O
at ADP O
clinician NOUN O
discretion NOUN O
. PUNCT O

This DET O
discovery NOUN O
dataset NOUN O
was AUX O
collected VERB O
by ADP O
a DET O
Japanese ADJ O
nationwide ADJ O
database NOUN O
project NOUN O
called VERB O
the DET O
Strategic PROPN B-LF
Research PROPN I-LF
Program PROPN I-LF
for ADP I-LF
Brain PROPN I-LF
Science PROPN I-LF
( PUNCT O
SRPBS PROPN B-AC
, PUNCT O
https://bicr.atr.jp/decnefpro/ X O
) PUNCT O
since SCONJ O
2014 NUM O
. PUNCT O

The DET O
ability NOUN O
of ADP O
glycine NOUN O
to PART O
hyperpolarize VERB O
cells NOUN O
depends VERB O
on ADP O
the DET O
co NOUN O
- NOUN O
expression NOUN O
of ADP O
the DET O
ion NOUN O
channel NOUN O
solute NOUN B-LF
carrier NOUN I-LF
family NOUN I-LF
12 NUM I-LF
( PUNCT I-LF
potassium NOUN I-LF
/ SYM I-LF
chloride NOUN I-LF
transporter NOUN I-LF
) PUNCT I-LF
, PUNCT I-LF
member NOUN I-LF
5b NOUN I-LF
( PUNCT O
KCC2 NOUN B-AC
) PUNCT O
and CCONJ O
the DET O
glycine NOUN O
receptor NOUN O
. PUNCT O

Two NUM O
randomised ADJ B-LF
controlled VERB I-LF
trials NOUN I-LF
( PUNCT O
RCTs NOUN B-AC
) PUNCT O
recently ADV O
evaluated VERB O
the DET O
risk NOUN O
of ADP O
adverse ADJ O
perinatal ADJ O
outcome NOUN O
after ADP O
a DET O
policy NOUN O
of ADP O
induction NOUN B-LF
of ADP I-LF
labour NOUN I-LF
( PUNCT O
IOL PROPN B-AC
) PUNCT O
at ADP O
41 NUM O
weeks NOUN O
as SCONJ O
compared VERB O
with ADP O
expectant ADJ O
management NOUN O
until ADP O
42 NUM O
weeks NOUN O
[ PUNCT O
6,7 NUM O
] PUNCT O
. PUNCT O

HR NOUN O
, PUNCT O
hazard NOUN O
ratio NOUN O
; PUNCT O
CI PROPN O
, PUNCT O
confidence NOUN O
interval NOUN O
; PUNCT O
ECOG PROPN B-AC
, PUNCT O
Eastern PROPN B-LF
Cooperative PROPN I-LF
Oncology PROPN I-LF
Group PROPN I-LF
; PUNCT O
DM NOUN O
, PUNCT O
diabetes NOUN O
mellitus NOUN O
; PUNCT O
HTN PROPN O
, PUNCT O
hypertension NOUN O
. PUNCT O

The DET O
transition NOUN O
from ADP O
ln(1 NOUN O
) PUNCT O
to ADP O
ln(2.62 NOUN O
) PUNCT O
over ADP O
130 NUM O
million NUM B-LF
years NOUN I-LF
implies VERB O
a DET O
Paleozoic ADJ O
long ADJ O
- ADJ O
term NOUN O
net ADJ O
diversification NOUN O
rate NOUN O
of ADP O
0.0202 NUM O
ln(species)/Myr NOUN B-AC
, PUNCT O
which PRON O
would AUX O
generate VERB O
more ADJ O
than ADP O
a DET O
40 ADJ O
- ADJ O
fold ADJ O
increase NOUN O
in ADP O
diversity NOUN O
over ADP O
190 NUM O
Myr NOUN B-AC
of ADP O
Mesozoic ADJ O
time NOUN O
. PUNCT O

Acetaminophen NOUN B-LF
( PUNCT O
APAP PROPN B-AC
) PUNCT O
is AUX O
a DET O
commonly ADV O
used VERB O
analgesic NOUN O
and CCONJ O
antipyretic NOUN O
that PRON O
can AUX O
cause VERB O
hepatotoxicity NOUN O
due ADP O
to ADP O
production NOUN O
of ADP O
toxic ADJ O
metabolites NOUN O
via ADP O
cytochrome NOUN B-LF
P450 PROPN I-LF
( PUNCT O
Cyp PROPN B-AC
) PUNCT O
1a2 NUM O
and CCONJ O
Cyp2e1 PROPN O
. PUNCT O

Publication NOUN O
bias NOUN O
was AUX O
suspected VERB O
in ADP O
both CCONJ O
the DET O
PCS PROPN B-AC
( PUNCT O
A NOUN O
) PUNCT O
and CCONJ O
MCS PROPN B-AC
( PUNCT O
B NOUN O
) PUNCT O
. PUNCT O
MCS PROPN B-AC
: PUNCT O
mental ADJ B-LF
component NOUN I-LF
summary NOUN I-LF
score NOUN I-LF
; PUNCT O
PCS PROPN B-AC
: PUNCT O
physical ADJ B-LF
component NOUN I-LF
summary NOUN I-LF
score NOUN I-LF
; PUNCT O
RFCA PROPN B-AC
: PUNCT O
radiofrequency NOUN B-LF
catheter NOUN I-LF
ablation NOUN I-LF
; PUNCT O
WMD PROPN B-AC
: PUNCT O
weighted VERB O
mean ADJ O
difference NOUN O
. PUNCT O

In ADP O
Saccharomyces PROPN O
cerevisiae NOUN O
, PUNCT O
replication NOUN O
origins NOUN O
isolated VERB O
in ADP O
DNA PROPN O
fragments NOUN O
are AUX O
known VERB O
as ADP O
autonomously ADV B-LF
replicating VERB I-LF
sequences NOUN I-LF
( PUNCT O
ARSs PROPN B-AC
) PUNCT O
. PUNCT O

The DET O
additional ADJ O
advantage NOUN O
of ADP O
NAATs PROPN B-AC
is AUX O
that SCONJ O
they PRON O
have VERB O
a DET O
real ADJ O
- PUNCT O
world NOUN O
sensitivity NOUN O
of ADP O
90%–96 NUM O
% NOUN O
, NOUN O
which PRON O
leads VERB O
to ADP O
a DET O
lower ADJ O
proportion NOUN O
of ADP O
untreated ADJ O
infections NOUN O
( PUNCT O
false ADJ O
negative ADJ O
tests NOUN O
) PUNCT O
compared VERB O
to ADP O
antigen NOUN O
- PUNCT O
based VERB O
methods NOUN O
( PUNCT O
direct ADJ O
immunofluorescence NOUN B-LF
( PUNCT O
IF PROPN B-AC
) PUNCT O
or CCONJ O
direct ADJ B-LF
fluorescent ADJ I-LF
antibody NOUN I-LF
( PUNCT O
DFA PROPN B-AC
) PUNCT O
and CCONJ O
enzyme NOUN O
- PUNCT O
linked VERB O
immunosorbent NOUN O
assay NOUN O
( PUNCT O
ELISA PROPN B-AC
) PUNCT O
or CCONJ O
enzyme NOUN B-LF
immunoassay NOUN I-LF
( PUNCT O
EIA PROPN B-AC
) PUNCT O
sensitivity NOUN O
65%–75 NUM O
% NOUN O
compared VERB O
to ADP O
NAAT PROPN B-AC
) PUNCT O
[ PUNCT O
5,6 NUM O
] PUNCT O
. PUNCT O

According VERB O
to ADP O
the DET O
United PROPN B-LF
Nations PROPN I-LF
Children PROPN I-LF
’s PART I-LF
Fund PROPN I-LF
( PUNCT O
UNICEF PROPN B-AC
) PUNCT O
, PUNCT O
with ADP O
respect NOUN O
to ADP O
breastfeeding NOUN O
, PUNCT O
every DET O
second NOUN O
counts VERB O
in ADP O
an DET O
infant NOUN O
’s PART O
life NOUN O
. PUNCT O

We PRON O
established VERB O
a DET O
working VERB O
group NOUN O
, PUNCT O
the DET O
Global PROPN B-LF
Respiratory PROPN I-LF
Hospitalizations PROPN I-LF
– PUNCT I-LF
Influenza PROPN I-LF
Proportion PROPN I-LF
Positive PROPN I-LF
( PUNCT O
GRIPP PROPN B-AC
) PUNCT O
Working PROPN O
Group PROPN O
. PUNCT O

Please AUX O
note VERB O
: PUNCT O
fixed VERB O
- PUNCT O
dose NOUN O
regimens NOUN O
are AUX O
in ADP O
square ADJ O
brackets NOUN O
. PUNCT O
3TC PROPN O
, PUNCT O
lamivudine NOUN O
; PUNCT O
ABC PROPN O
, PUNCT O
abacavir NOUN O
; PUNCT O
d4 PROPN B-AC
T PROPN B-AC
, PUNCT O
stavudine NOUN B-LF
; PUNCT O
EFV PROPN B-AC
, PUNCT O
efavirenz NOUN B-LF
; PUNCT O
FTC PROPN O
, PUNCT O
emtricitabine NOUN O
; PUNCT O
LPV PROPN O
/ SYM O
r NOUN O
, PUNCT O
lopinavir NOUN O
/ SYM O
ritonavir NOUN O
; PUNCT O
NVP PROPN B-AC
, PUNCT O
nevirapine NOUN B-LF
; PUNCT O
TDF PROPN B-AC
, PUNCT O
tenofovir NOUN B-LF
; PUNCT O
ZDV PROPN B-AC
, PUNCT O
zidovudine NOUN B-LF
. PUNCT O

To PART O
account VERB O
for ADP O
the DET O
phenotypic ADJ O
drug NOUN O
tolerance NOUN O
of ADP O
Mycobacterium NOUN O
tuberculosis NOUN O
( PUNCT O
Mtb PROPN O
) PUNCT O
bacilli NOUN O
in ADP O
nodule NOUN O
and CCONJ O
cavity NOUN O
caseum NOUN O
[ PUNCT O
29 NUM O
] PUNCT O
, PUNCT O
additional ADJ O
population NOUN O
PK NOUN B-AC
/ SYM O
PD NOUN B-AC
distributions NOUN O
were AUX O
simulated ADJ O
using VERB O
caseum NOUN B-LF
- PUNCT I-LF
specific ADJ I-LF
minimum ADJ I-LF
bactericidal ADJ I-LF
concentration NOUN I-LF
MBC90 PROPN O
( PUNCT O
CasMBC90 PROPN B-AC
) PUNCT O
as ADP O
the DET O
PD NOUN B-AC
parameter NOUN O
to PART O
capture VERB O
the DET O
drugs NOUN O
’ PART O
killing VERB O
potential NOUN O
in ADP O
the DET O
caseous ADJ O
core NOUN O
of ADP O
necrotic ADJ O
lesions NOUN O
( PUNCT O
Fig PROPN O
9B NUM O
) PUNCT O
. PUNCT O
None NOUN O
of ADP O
the DET O
drugs NOUN O
were AUX O
able ADJ O
to PART O
reach VERB O
full ADJ O
efficacy NOUN O
in ADP O
this DET O
hard ADJ O
- PUNCT O
to PART O
- PUNCT O
treat VERB O
lesion NOUN O
, PUNCT O
and CCONJ O
MFX PROPN B-AC
was AUX O
the DET O
only ADJ O
drug NOUN O
to PART O
show VERB O
efficacy NOUN O
for ADP O
31 NUM O
% NOUN O
of ADP O
the DET O
simulated ADJ O
population NOUN O
. PUNCT O

Postnatal ADJ O
weight NOUN O
gain NOUN O
in ADP O
extremely ADV B-LF
low ADJ I-LF
birth NOUN I-LF
weight NOUN I-LF
infants NOUN I-LF
( PUNCT O
ELBWIs PROPN B-AC
) PUNCT O
is AUX O
a DET O
critical ADJ O
issue NOUN O
for ADP O
neurodevelopment NOUN O
outcomes NOUN O
[ PUNCT O
1 NUM O
] PUNCT O
. PUNCT O

MVC NOUN B-AC
maximal ADJ O
voluntary ADJ O
contraction NOUN O
, PUNCT O
VA NOUN B-AC
voluntary ADJ B-LF
activation NOUN I-LF
, PUNCT O
LFF NOUN B-AC
low ADJ B-LF
frequency NOUN I-LF
fatigue NOUN I-LF
index NOUN O
Db100Hz NOUN O
double ADJ O
electrical ADJ O
pulse NOUN O
at ADP O
100Hz NUM O
, PUNCT O
Db10Hz NOUN O
double ADJ O
electrical ADJ O
pulse NOUN O
at ADP O
10Hz NUM O
, PUNCT O
Single ADJ B-LF
Twitch NOUN I-LF
single ADJ O
electrical ADJ O
pulse NOUN O
, PUNCT O
ST PROPN B-AC
- PUNCT O
RFD PROPN B-AC
Rate NOUN B-LF
of ADP I-LF
force NOUN I-LF
development NOUN I-LF
of ADP O
single ADJ B-LF
twitch NOUN I-LF
, PUNCT O
ST-½RRT PROPN B-AC
Rate NOUN O
of ADP O
relaxation NOUN O
of ADP O
single ADJ B-LF
twitch NOUN I-LF
, PUNCT O
ISR NOUN B-AC
intra ADJ B-LF
set NOUN I-LF
rest NOUN I-LF
configuration NOUN O
, PUNCT O
TS NOUN B-AC
traditional ADJ B-LF
set NOUN I-LF
configuration NOUN O
. PUNCT O

GDM NOUN B-AC
, PUNCT O
gestational ADJ B-LF
diabetes NOUN I-LF
mellitus NOUN I-LF
; PUNCT O
PUFA NOUN B-AC
, PUNCT O
polyunsaturated ADJ B-LF
fatty ADJ I-LF
acid NOUN I-LF
. PUNCT O

This DET O
instrument NOUN O
has VERB O
the DET O
advantage NOUN O
of ADP O
very ADV O
sensitive ADJ B-LF
avalanche NOUN I-LF
photodiode NOUN I-LF
detectors NOUN I-LF
( PUNCT O
SPADs PROPN B-AC
) PUNCT O
that PRON O
are AUX O
capable ADJ O
at ADP O
detecting VERB O
nM NOUN O
concentrations NOUN O
of ADP O
protein NOUN O
. PUNCT O

uCTXII PROPN B-AC
: PUNCT O
C PROPN B-LF
- PROPN I-LF
Terminal PROPN I-LF
Telopeptide NOUN I-LF
type NOUN I-LF
II NUM I-LF

DAPI PROPN B-AC
( PUNCT O
4′ NUM B-LF
, PUNCT I-LF
6 NUM I-LF
- PUNCT I-LF
diamidino-2 NOUN I-LF
- PUNCT I-LF
phenylindole NOUN I-LF
dihydrochloride NOUN I-LF
) PUNCT O
was AUX O
from ADP O
Invitrogen PROPN O
. PUNCT O

As ADP O
with ADP O
all DET O
noncoding NOUN O
sequences NOUN O
, PUNCT O
small ADJ O
insertion NOUN B-LF
or CCONJ I-LF
deletion NOUN I-LF
( PUNCT O
indel NOUN B-AC
) PUNCT O
events NOUN O
can AUX O
also ADV O
play VERB O
important ADJ O
roles NOUN O
. PUNCT O

( PUNCT O
E NOUN O
, PUNCT O
F NOUN O
, PUNCT O
H NOUN O
, PUNCT O
and CCONJ O
I NOUN O
) PUNCT O
Red ADJ O
and CCONJ O
green ADJ O
cholera NOUN B-LF
toxin NOUN I-LF
( PUNCT O
CT NOUN B-AC
) PUNCT O
was AUX O
injected VERB O
into ADP O
the DET O
visual ADJ O
( PUNCT O
V1 NOUN B-AC
, PUNCT O
open ADJ O
arrowhead NOUN O
in ADP O
[ X O
H NOUN O
] PUNCT O
) PUNCT O
and CCONJ O
somatosensory ADJ O
( PUNCT O
S1 NOUN B-AC
, PUNCT O
open ADJ O
arrowhead NOUN O
in ADP O
[ X O
E NOUN O
] PUNCT O
) PUNCT O
cortex NOUN O
, PUNCT O
respectively ADV O
, PUNCT O
of ADP O
wild ADJ O
- PUNCT O
type NOUN O
and CCONJ O
Sema6A−/− NOUN O
adult NOUN O
mice NOUN O
. PUNCT O

BCC PROPN B-AC
, PUNCT O
behavior NOUN B-LF
change NOUN I-LF
communication NOUN I-LF
; PUNCT O
CNS PROPN B-AC
, PUNCT O
well ADJ O
- PUNCT O
baby NOUN O
consultation PROPN O
( PUNCT O
consultation PROPN O
du X O
nourrisson X O
sain PROPN O
) PUNCT O

Subcortical ADJ O
beta NOUN O
bursting NOUN O
is AUX O
now ADV O
a DET O
target NOUN O
for ADP O
developing VERB O
adaptive ADJ O
deep ADJ B-LF
brain NOUN I-LF
stimulation NOUN I-LF
( PUNCT O
DBS PROPN B-AC
) PUNCT O
technologies NOUN O
that PRON O
seek VERB O
to PART O
directly ADV O
reshape VERB O
the DET O
temporal ADJ O
profile NOUN O
of ADP O
beta NOUN O
events NOUN O
and CCONJ O
thereby ADV O
provide VERB O
evidence NOUN O
for ADP O
their PRON O
causal ADJ O
role NOUN O
[ X O
70,74,86–88 NUM O
] PUNCT O
. PUNCT O

Clinacanthus NOUN B-LF
nutans NOUN I-LF
( PUNCT O
CN PROPN B-AC
) PUNCT O
has AUX O
gained VERB O
much ADJ O
attention NOUN O
because SCONJ O
of ADP O
its PRON O
anticancer NOUN O
properties NOUN O
, PUNCT O
but CCONJ O
its PRON O
mechanism NOUN O
remains VERB O
unclear ADJ O
. PUNCT O

ILP1 PROPN B-AC
also ADV O
contains VERB O
two NUM O
cysteine NOUN O
– PUNCT O
cysteine NOUN O
motifs NOUN O
that PRON O
are AUX O
weakly ADV O
predicted VERB O
to PART O
be AUX O
palmitoylated VERB O
by ADP O
CSS PROPN O
- PUNCT O
PALM PROPN O
[ PUNCT O
30 NUM O
] NOUN O
, PUNCT O
and CCONJ O
thus ADV O
a DET O
quadruple ADJ B-LF
C95S NOUN I-LF
, PUNCT I-LF
C96S PROPN I-LF
, PUNCT I-LF
C273S PROPN I-LF
, PUNCT I-LF
C274S PROPN I-LF
mutant NOUN I-LF
( PUNCT O
4Cys NOUN B-AC
) PUNCT O
was AUX O
also ADV O
generated VERB O
. PUNCT O

CEA PROPN B-AC
, PUNCT O
carcinoembryonic ADJ B-LF
antigen NOUN I-LF
; PUNCT O
DD PROPN O
, PUNCT O
dedifferentiated VERB O
; PUNCT O
FEV1 PROPN B-AC
, PUNCT O
forced VERB B-LF
expiratory ADJ I-LF
volume NOUN I-LF
in ADP I-LF
a DET I-LF
second ADJ I-LF
; PUNCT O
FVC PROPN B-AC
, PUNCT O
forced VERB B-LF
vital ADJ I-LF
capacity NOUN I-LF
; PUNCT O
MD PROPN O
, PUNCT O
moderately ADV O
differentiated VERB O
; PUNCT O
PD PROPN O
, PUNCT O
poorly ADV O
differentiated VERB O
; PUNCT O
WD PROPN O
, PUNCT O
well ADV O
- PUNCT O
differentiated VERB O
. PUNCT O

It PRON O
is AUX O
a DET O
gelatine NOUN O
based VERB O
biodegradable ADJ O
slow ADV O
- PUNCT O
releasing VERB O
- PUNCT O
device NOUN O
containing VERB O
33 NUM O
% NOUN O
( PUNCT O
2.5 NUM O
mg NOUN O
) PUNCT O
CHX PROPN B-AC
. PUNCT O
This DET O
small ADJ O
chip NOUN O
( PUNCT O
5 NUM O
mm NOUN O
x SYM O
4 NUM O
mm NOUN O
x SYM O
0.35 NUM O
mm NOUN O
, PUNCT O
7 NUM O
mg NOUN O
) PUNCT O
is AUX O
placed VERB O
in ADP O
periodontal ADJ O
pockets NOUN O
and CCONJ O
releases VERB O
CHX PROPN B-AC
for ADP O
over ADP O
7 NUM O
days NOUN O
in ADP O
clinical ADJ O
settings NOUN O
. PUNCT O
[ X O
15 X O
] X O
The DET O
second ADJ O
is AUX O
a DET O
xanthan NOUN O
based VERB O
gel NOUN O
, PUNCT O
called VERB O
Chlosite PROPN O
, PUNCT O
containing VERB O
0.5 NUM O
% NOUN O
chlorhexidine- NOUN B-LF
digluconate NOUN O
and CCONJ O
1.0 NUM O
% NOUN O
of ADP O
– PUNCT O
dihydrochlorite NOUN O
. PUNCT O

Viability NOUN O
of ADP O
the DET O
embryos NOUN O
was AUX O
checked VERB O
at ADP O
the DET O
indicated VERB O
time NOUN O
points NOUN O
( PUNCT O
EDD PROPN B-AC
= PUNCT O
embryonic ADJ B-LF
development NOUN I-LF
day NOUN I-LF
) PUNCT O
. PUNCT O

The DET O
package NOUN O
of ADP O
CoC PROPN B-AC
interventions NOUN O
improved VERB O
CoC PROPN B-AC
completion NOUN O
( PUNCT O
adjusted VERB B-LF
odds NOUN I-LF
ratio NOUN I-LF
[ PUNCT O
AOR NOUN B-AC
] PUNCT O
for ADP O
DiD PROPN B-AC
= SYM O
1.77 NUM O
; PUNCT O
95 NUM O
% NOUN O
confidence NOUN B-LF
interval NOUN I-LF
[ PUNCT O
CI NOUN B-AC
] PUNCT O
: PUNCT O
1.08 NUM O
to PART O
2.92 NUM O
; PUNCT O
p NOUN O
= SYM O
0.024 NUM O
) PUNCT O
. PUNCT O

DMT PROPN B-AC
, PUNCT O
disease NOUN B-LF
- PUNCT I-LF
modifying VERB I-LF
therapy NOUN I-LF
; PUNCT O
ICD PROPN B-AC
, PUNCT O
International PROPN B-LF
Classification PROPN I-LF
of ADP I-LF
Diseases PROPN I-LF
; PUNCT O
MS PROPN B-AC
, PUNCT O
multiple ADJ B-LF
sclerosis NOUN I-LF
. PUNCT O

The DET O
Systolic PROPN B-LF
Blood PROPN I-LF
Pressure PROPN I-LF
Intervention PROPN I-LF
Trial PROPN I-LF
( PUNCT O
SPRINT PROPN B-AC
) PUNCT O
and CCONJ O
the DET O
Heart PROPN B-LF
Outcomes PROPN I-LF
Prevention PROPN I-LF
Evaluation-3 PROPN I-LF
( PUNCT O
HOPE-3 PROPN B-AC
) PUNCT O
study NOUN O
provide VERB O
data NOUN O
that PRON O
complement VERB O
our PRON O
analyses NOUN O
and CCONJ O
support VERB O
these DET O
results NOUN O
[ PUNCT O
32,33 NUM O
] PUNCT O
. PUNCT O

NFATs NOUN B-AC
often ADV O
up ADV O
- PROPN O
regulate VERB O
gene NOUN O
transcription NOUN O
in ADP O
cooperation NOUN O
with ADP O
other ADJ O
transcription NOUN O
factors NOUN O
, PUNCT O
most ADV O
commonly ADV O
AP-1 PROPN O
, PUNCT O
the DET O
combination NOUN O
being AUX O
required VERB O
for ADP O
the DET O
expression NOUN O
of ADP O
interleukin NOUN B-LF
( PUNCT O
IL)-2 NOUN B-AC
[ PUNCT O
6 NUM O
] PUNCT O
, PUNCT O
IL-3 NOUN B-AC
[ PUNCT O
7 NUM O
] PUNCT O
, PUNCT O
granulocyte NOUN B-LF
- PROPN I-LF
macrophage NOUN I-LF
colony NOUN I-LF
- PROPN I-LF
stimulating VERB I-LF
factor NOUN I-LF
( PUNCT O
GM PROPN B-AC
- PROPN B-AC
CSF PROPN B-AC
) PUNCT O
[ PUNCT O
8 NUM O
] PUNCT O
, PUNCT O
IL-4 NOUN B-AC
[ PUNCT O
9 NUM O
] PUNCT O
, PUNCT O
IL-5 NOUN B-AC
[ PUNCT O
10 NUM O
] PUNCT O
, PUNCT O
IL-13 NOUN B-AC
[ PUNCT O
6 NUM O
] PUNCT O
, PUNCT O
interferon NOUN B-LF
gamma NOUN I-LF
( PUNCT O
IFN PROPN B-AC
- PROPN B-AC
γ PROPN B-AC
) PUNCT O
[ PUNCT O
11 NUM O
] PUNCT O
, PUNCT O
Fas NOUN B-LF
ligand NOUN I-LF
( PUNCT O
FasL PROPN B-AC
) PUNCT O
[ PUNCT O
12 NUM O
] PUNCT O
, PUNCT O
CD25 NOUN O
[ PUNCT O
13 NUM O
] PUNCT O
, PUNCT O
Cox2 NOUN O
[ PUNCT O
14 NUM O
] PUNCT O
, PUNCT O
IL-8 NOUN B-AC
, PUNCT O
and CCONJ O
migration NOUN B-LF
inhibitory ADJ I-LF
factor NOUN I-LF
1 NUM I-LF
alpha NOUN I-LF
( PUNCT O
MIF-1α PROPN B-AC
) PUNCT O
[ PUNCT O
11 NUM O
] PUNCT O
. PUNCT O

The DET O
Pseudomonas PROPN O
aeruginosa NOUN O
MvfR PROPN O
- PUNCT O
dependent ADJ O
QS NOUN B-AC
regulatory ADJ O
pathway NOUN O
controls VERB O
the DET O
expression NOUN O
of ADP O
key ADJ O
virulence NOUN O
genes NOUN O
; PUNCT O
and CCONJ O
is AUX O
activated VERB O
via ADP O
the DET O
extracellular ADJ O
signals NOUN O
4 NUM B-LF
- PUNCT I-LF
hydroxy-2 NOUN I-LF
- PUNCT I-LF
heptylquinoline NOUN I-LF
( PUNCT O
HHQ PROPN B-AC
) PUNCT O
and CCONJ O
3,4 NUM B-LF
- PUNCT I-LF
dihydroxy-2 NOUN I-LF
- PUNCT I-LF
heptylquinoline NOUN I-LF
( PUNCT O
PQS PROPN B-AC
) PUNCT O
, PUNCT O
whose DET O
syntheses NOUN O
depend VERB O
on ADP O
anthranilic ADJ B-LF
acid NOUN I-LF
( PUNCT O
AA PROPN B-AC
) PUNCT O
, PUNCT O
the DET O
primary ADJ O
precursor NOUN O
of ADP O
4 NUM B-LF
- PUNCT I-LF
hydroxy-2 NOUN I-LF
- PUNCT I-LF
alkylquinolines NOUN I-LF
( PUNCT O
HAQs PROPN B-AC
) PUNCT O
. PUNCT O

The DET O
various ADJ O
aminoalcohol NOUN O
derivatives NOUN O
, PUNCT O
including VERB O
2-(ethylamino)ethanol NOUN O
, PUNCT O
N NOUN O
- NOUN O
methylethanolamine NOUN O
, PUNCT O
diethanolamine NOUN O
, PUNCT O
and CCONJ O
triethanolamine NOUN O
, PUNCT O
have AUX O
been AUX O
verified VERB O
as ADP O
activators NOUN O
to PART O
enhance VERB O
bovine ADJ B-LF
intestine NOUN I-LF
ALP NOUN I-LF
( PUNCT O
BIALP PROPN B-AC
) PUNCT O
activity NOUN O
to PART O
degrade VERB O
p NOUN B-LF
- NOUN I-LF
nitrophenyl NOUN I-LF
phosphate NOUN I-LF
( PUNCT O
pNPP NOUN B-AC
) PUNCT O
[ PUNCT O
20 NUM O
] PUNCT O
. PUNCT O

The DET O
mean ADJ O
( PUNCT O
95 NUM O
% NOUN O
confidence NOUN O
interval NOUN O
) NOUN O
diagnostic ADJ O
accuracy NOUN O
of ADP O
selected VERB O
modalities NOUN O
was AUX O
as SCONJ O
follows VERB O
: PUNCT O
Meckel PROPN B-AC
’s PART B-AC
scan NOUN B-AC
, PUNCT O
21.4 NUM O
% NOUN O
( PUNCT O
5.7%-51.2 NUM O
% NOUN O
) NOUN O
; PUNCT O
capsule NOUN O
endoscopy NOUN O
, PUNCT O
35.7 NUM O
% NOUN O
( PUNCT O
14.0%-64.4 NUM O
% NOUN O
) NOUN O
; PUNCT O
balloon NOUN B-LF
- PUNCT I-LF
assisted VERB I-LF
enteroscopy NOUN I-LF
( PUNCT O
BAE PROPN B-AC
) NOUN O
, PUNCT O
85.0 NUM O
% NOUN O
( PUNCT O
61.1%-96.0 NUM O
% NOUN O
) NOUN O
; PUNCT O
angiography NOUN O
, PUNCT O
0.0 NUM O
% NOUN O
( PUNCT O
0.0%-80.2 NUM O
% NOUN O
) NOUN O
; PUNCT O
computed VERB O
tomography NOUN O
, PUNCT O
31.8 NUM O
% NOUN O
( PUNCT O
14.7%-54.9 NUM O
% NOUN O
) NOUN O
; PUNCT O
and CCONJ O
small ADJ O
- PUNCT O
bowel NOUN O
follow NOUN O
- PUNCT O
through NOUN O
, PUNCT O
62.5 NUM O
% NOUN O
( PUNCT O
25.9%-90.0 NUM O
% NOUN O
) NOUN O
. NOUN O

PE PROPN B-AC
= PUNCT O
Patient NOUN B-LF
Empowerment NOUN I-LF
, PUNCT O
GSE PROPN B-AC
= PUNCT O
General PROPN B-LF
Self PROPN I-LF
- PUNCT I-LF
Efficacy NOUN I-LF
, PUNCT O
TCS PROPN B-AC
= PUNCT O
Transition PROPN B-LF
Competence NOUN I-LF
Scale NOUN I-LF
, PUNCT O
PAM PROPN B-AC
= PUNCT O
Patient NOUN O
Activation PROPN O
Measurement PROPN O
– PUNCT O
German PROPN O
Youth PROPN O
Version PROPN O
. PUNCT O

Developmental ADJ O
task NOUN O
- PUNCT O
based VERB O
functional ADJ B-LF
magnetic ADJ I-LF
resonance NOUN I-LF
imaging NOUN I-LF
( PUNCT O
fMRI NOUN B-AC
) PUNCT O
studies NOUN O
indicate VERB O
that SCONJ O
core NOUN O
regions NOUN O
supporting VERB O
cognitive ADJ O
control NOUN O
( PUNCT O
e.g. X O
, PUNCT O
anterior ADJ B-LF
cingulate NOUN I-LF
cortex NOUN I-LF
[ X O
ACC PROPN B-AC
] PUNCT O
and CCONJ O
anterior ADJ B-LF
insula NOUN I-LF
[ X O
aIns NOUN B-AC
] PUNCT O
) PUNCT O
are AUX O
engaged VERB O
in ADP O
adolescence NOUN O
during ADP O
cognitive ADJ O
tasks NOUN O
, PUNCT O
but CCONJ O
their PRON O
blood NOUN B-LF
oxygen NOUN I-LF
level NOUN I-LF
– PUNCT I-LF
dependent ADJ I-LF
( PUNCT O
BOLD PROPN B-AC
) PUNCT O
signal NOUN O
activation NOUN O
[ X O
3,4 NUM O
] PUNCT O
and CCONJ O
connectivity NOUN O
with ADP O
other ADJ O
brain NOUN O
regions NOUN O
continue VERB O
to PART O
increase VERB O
into ADP O
adulthood NOUN O
[ X O
5–7 NUM O
] PUNCT O
. PUNCT O

A DET O
candidate NOUN O
target NOUN O
pathway NOUN O
is AUX O
quorum NOUN B-LF
sensing NOUN I-LF
( PUNCT O
QS PROPN B-AC
) PUNCT O
, PUNCT O
which PRON O
many ADJ O
bacterial ADJ O
pathogens NOUN O
use VERB O
to PART O
coordinately ADV O
regulate VERB O
virulence NOUN O
determinants NOUN O
. PUNCT O

Wall NOUN B-LF
- PUNCT I-LF
associated VERB I-LF
kinases NOUN I-LF
( PUNCT O
WAKs PROPN B-AC
) PUNCT O
comprise VERB O
a DET O
subfamily NOUN O
of ADP O
proteins NOUN O
within ADP O
the DET O
receptor NOUN B-LF
- PUNCT I-LF
like ADJ I-LF
kinase NOUN I-LF
( PUNCT O
RLK PROPN B-AC
) PUNCT O
superfamily NOUN O
. PUNCT O

Early ADJ B-LF
repolarization NOUN I-LF
pattern NOUN I-LF
( PUNCT O
ERP NOUN B-AC
) PUNCT O
on ADP O
electrocardiogram NOUN O
was AUX O
associated VERB O
with ADP O
idiopathic ADJ O
ventricular ADJ O
fibrillation NOUN O
and CCONJ O
sudden ADJ O
cardiac ADJ O
arrest NOUN O
in ADP O
a DET O
case NOUN O
- PUNCT O
control NOUN O
study NOUN O
and CCONJ O
with ADP O
cardiovascular ADJ O
mortality NOUN O
in ADP O
a DET O
Finnish ADJ O
community NOUN O
- PUNCT O
based VERB O
sample NOUN O
. PUNCT O

NF54CSA PROPN B-AC
, PUNCT O
Plasmodium NOUN O
falciparum NOUN O
isolate NOUN O
NF54 PROPN B-AC
selected VERB O
for ADP O
CSA NOUN B-AC
adhesion NOUN O
; PUNCT O
VAR2CSA PROPN B-AC
, PUNCT O
variant NOUN B-LF
surface NOUN I-LF
antigen NOUN I-LF
2 NUM I-LF
- PUNCT I-LF
CSA NOUN I-LF
; PUNCT O
T934A PROPN O
, PUNCT O
threonine934 NOUN O
alanine NOUN O
. PUNCT O

Age NOUN O
- PUNCT O
standardized VERB O
incidence NOUN O
rates NOUN O
( PUNCT O
per ADP O
million NUM O
person NOUN O
- PUNCT O
years NOUN O
) PUNCT O
in ADP O
males NOUN O
and CCONJ O
females NOUN O
were AUX O
34.0 NUM O
( PUNCT O
95 NUM B-LF
% NOUN I-LF
confidence NOUN I-LF
interval NOUN I-LF
[ PUNCT O
CI NOUN O
] X O
28.9–39.1 NUM O
) PUNCT O
and CCONJ O
26.2 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
21.5–30.7 NUM O
) PUNCT O
for ADP O
LL PROPN B-AC
, PUNCT O
10.5 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
7.7–13.3 NUM O
) PUNCT O
and CCONJ O
12.5 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
9.4–15.7 NUM O
) PUNCT O
for ADP O
HL PROPN B-AC
, PUNCT O
12.5 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
9.3–15.4 NUM O
) PUNCT O
and CCONJ O
7.7 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
5.2–10.2 NUM O
) PUNCT O
for ADP O
NHL PROPN B-AC
( PUNCT O
except SCONJ O
for ADP O
Burkitt PROPN O
lymphomas NOUN O
) PUNCT O
, PUNCT O
and CCONJ O
3.2 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
1.6–4.7 NUM O
) PUNCT O
and CCONJ O
1.5 NUM O
( PUNCT O
95 NUM B-AC
% NOUN B-AC
CI NOUN B-AC
0.4–2.5 NUM O
) PUNCT O
for ADP O
Burkitt PROPN O
lymphomas NOUN O
. PUNCT O

AMPA PROPN B-AC
, PUNCT O
α NOUN B-LF
- PUNCT I-LF
amino-3 NOUN I-LF
- PUNCT I-LF
hydroxy-5 NOUN I-LF
- PUNCT I-LF
methyl-4 NOUN I-LF
- PUNCT I-LF
isoxazolepropionic NOUN I-LF
acid NOUN I-LF
; PUNCT O
DiSs PROPN B-AC
, PUNCT O
dually ADV B-LF
innervated VERB I-LF
spines NOUN I-LF
; PUNCT O
EPSP PROPN B-AC
, PUNCT O
excitatory ADJ B-LF
postsynaptic ADJ I-LF
potential NOUN I-LF
; PUNCT O
IPSP PROPN B-AC
, PUNCT O
inhibitory ADJ B-LF
postsynaptic ADJ I-LF
potential NOUN I-LF
; PUNCT O
NMDA PROPN B-AC
, PUNCT O
N NOUN B-LF
- PUNCT I-LF
Methyl NOUN I-LF
- PUNCT I-LF
D NOUN I-LF
- PUNCT I-LF
aspartate NOUN I-LF
. PUNCT O

AFP PROPN B-AC
, PUNCT O
α NOUN B-LF
- PUNCT I-LF
fetoprotein NOUN I-LF
; PUNCT O
ALT PROPN B-AC
, PUNCT O
alanine NOUN B-LF
transaminase NOUN I-LF
; PUNCT O
CLIP PROPN B-AC
, PUNCT O
Cancer PROPN B-LF
of ADP I-LF
the DET I-LF
Liver PROPN I-LF
Italian PROPN I-LF
Program PROPN I-LF
; PUNCT O
CTP PROPN B-AC
, PUNCT O
Child PROPN B-LF
- PUNCT I-LF
Turcotte PROPN I-LF
- PUNCT I-LF
Pugh PROPN I-LF
; PUNCT O
HBsAg PROPN B-AC
, PUNCT O
hepatitis NOUN B-LF
B NOUN I-LF
surface NOUN I-LF
antigen NOUN I-LF
; PUNCT O
HCV PROPN B-AC
, PUNCT O
hepatitis NOUN O
C NOUN O
; PUNCT O
INR NOUN B-AC
, PUNCT O
international ADJ B-LF
normalized VERB I-LF
ratio NOUN I-LF
; PUNCT O
MELD PROPN B-AC
, PUNCT O
model NOUN B-LF
for ADP I-LF
end ADJ I-LF
- PUNCT I-LF
stage NOUN I-LF
liver NOUN I-LF
disease NOUN I-LF
; PUNCT O
PT PROPN B-AC
, PUNCT O
prothrombin NOUN B-LF
time NOUN I-LF
; PUNCT O
SD PROPN B-AC
, PUNCT O
standard ADJ B-LF
deviation NOUN I-LF
; PUNCT O
SR PROPN B-AC
, PUNCT O
surgical ADJ B-LF
resection NOUN I-LF
; PUNCT O
TACE PROPN B-AC
, PUNCT O
transarterial ADJ B-LF
chemoembolization NOUN I-LF
; PUNCT O
TIS PROPN B-AC
, PUNCT O
Taipei PROPN B-LF
Integrated PROPN I-LF
Scoring PROPN I-LF
System PROPN I-LF

GLM PROPN B-AC
, PUNCT O
general ADJ B-LF
linear ADJ I-LF
model NOUN I-LF
; PUNCT O
OFC PROPN B-AC
, PUNCT O
orbitofrontal ADJ B-LF
cortex NOUN I-LF
. PUNCT O

NSAID PROPN B-AC
, PUNCT O
non ADJ B-LF
- PUNCT I-LF
steroidal ADJ I-LF
anti ADJ I-LF
- PUNCT I-LF
inflammatory ADJ I-LF
drug NOUN I-LF
; PUNCT O
RT PROPN O
- PUNCT O
PCR PROPN O
, PUNCT O
reverse ADJ O
transcription NOUN O
polymerase NOUN O
chain NOUN O
reaction NOUN O
; PUNCT O
SARS PROPN B-AC
- PUNCT B-AC
CoV-2 PROPN B-AC
, PUNCT O
severe ADJ B-LF
acute ADJ I-LF
respiratory ADJ I-LF
syndrome NOUN I-LF
coronavirus NOUN I-LF
2 NUM I-LF
. PUNCT O

AUD PROPN O
, PUNCT O
Australian ADJ O
dollars NOUN O
; PUNCT O
DALY PROPN B-AC
, PUNCT O
disability NOUN B-LF
- PUNCT I-LF
adjusted VERB I-LF
life NOUN I-LF
year NOUN I-LF
; PUNCT O
NZ PROPN O
, PUNCT O
New PROPN O
Zealand PROPN O
. PUNCT O

Data PROPN O
- PUNCT O
sharing NOUN O
platforms NOUN O
such ADJ O
as ADP O
Clinical PROPN O
Study PROPN O
Data PROPN O
Request PROPN O
, PUNCT O
the DET O
Yale PROPN B-LF
University PROPN I-LF
Open PROPN I-LF
Data PROPN I-LF
Access PROPN I-LF
( PUNCT O
YODA PROPN B-AC
) PUNCT O
Project PROPN O
and CCONJ O
Vivli PROPN O
were AUX O
created VERB O
to PART O
facilitate VERB O
data NOUN O
- PUNCT O
sharing NOUN O
and CCONJ O
to PART O
ensure VERB O
that SCONJ O
clinical ADJ O
trial NOUN O
data NOUN O
are AUX O
FAIR PROPN B-AC
( PUNCT O
Findable ADJ B-LF
, PUNCT I-LF
Accessible ADJ I-LF
, PUNCT I-LF
Interoperable ADJ I-LF
and CCONJ I-LF
Reusable ADJ I-LF
) PUNCT O
[ PUNCT O
5 NUM O
] PUNCT O
. PUNCT O

We PRON O
further ADV O
analyzed VERB O
primary ADJ B-LF
human ADJ I-LF
monocyte NOUN I-LF
- PUNCT I-LF
derived VERB I-LF
macrophages NOUN I-LF
( PUNCT O
PHMDMs PROPN B-AC
) PUNCT O
differentiated VERB O
from ADP O
CD14 NOUN O
+ NOUN O
monocytes NOUN O
. PUNCT O

ISS PROPN O
: PUNCT O
Injury NOUN O
severity NOUN O
score NOUN O
, PUNCT O
ER NOUN B-AC
: PUNCT O
emergency NOUN B-LF
room NOUN I-LF
, PUNCT O
DM NOUN O
: PUNCT O
Diabetes NOUN O
mellitus NOUN O
, PUNCT O
SBP NOUN O
: PUNCT O
Systolic ADJ O
blood NOUN O
pressure NOUN O
, PUNCT O
APC NOUN B-AC
: PUNCT O
Anterior ADJ O
- PUNCT O
posterior ADJ O
compression NOUN O
, PUNCT O
LC NOUN O
: PUNCT O
Lateral ADJ O
compression NOUN O
, PUNCT O
VS NOUN O
: PUNCT O
Vertical ADJ O
shear NOUN O
. PUNCT O

As SCONJ O
described VERB O
below ADV O
, PUNCT O
we PRON O
have AUX O
tested VERB O
both CCONJ O
double ADJ O
- PUNCT O
stranded ADJ O
( PUNCT O
dsDNA NOUN B-AC
) PUNCT O
and CCONJ O
single ADJ B-LF
- PUNCT I-LF
stranded ADJ I-LF
DNA NOUN I-LF
( PUNCT O
ssDNA NOUN B-AC
) PUNCT O
using VERB O
two NUM O
methods NOUN O
of ADP O
staining VERB O
with ADP O
fluorophores NOUN O
, PUNCT O
and CCONJ O
we PRON O
report VERB O
here ADV O
the DET O
proof NOUN O
of ADP O
concept NOUN O
demonstrating VERB O
that SCONJ O
ssDNA NOUN B-AC
shows VERB O
sequence NOUN O
- PUNCT O
specific ADJ O
responses NOUN O
to ADP O
a DET O
variety NOUN O
of ADP O
volatile ADJ O
compounds NOUN O
and CCONJ O
that SCONJ O
libraries NOUN O
of ADP O
these DET O
materials NOUN O
can AUX O
be AUX O
efficiently ADV O
screened VERB O
for ADP O
odor NOUN O
responses NOUN O
. PUNCT O

MglA PROPN B-AC
is AUX O
an DET O
ortholog NOUN O
of ADP O
the DET O
stringent ADJ B-LF
starvation NOUN I-LF
protein NOUN I-LF
A PROPN I-LF
( PUNCT O
SspA PROPN B-AC
) PUNCT O
from ADP O
Escherichia PROPN O
coli PROPN O
( PUNCT O
the DET O
two NUM O
proteins NOUN O
share VERB O
21 NUM O
% NOUN O
identity NOUN O
and CCONJ O
34 NUM O
% NOUN O
similarity NOUN O
at ADP O
the DET O
primary ADJ O
amino NOUN O
acid NOUN O
level NOUN O
) PUNCT O
. PUNCT O